data_1cky_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1cky _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.484 ' CE ' ' HA ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.299 0.571 . . . . 0.0 109.584 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 59.59 69.76 0.69 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -0.861 . . . . 0.0 109.595 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.34 54.17 1.2 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.284 -0.885 . . . . 0.0 109.327 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.514 ' O ' ' CG2' ' A' ' 9' ' ' ILE . 1.1 mp -60.23 -14.06 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.207 -0.933 . . . . 0.0 110.266 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.567 ' O ' ' N ' ' A' ' 12' ' ' GLY . 2.8 mm -40.13 161.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -66.7 53.66 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.016 -1.053 . . . . 0.0 109.147 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 10' ' ' ILE . . . -145.22 2.22 1.11 Allowed Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.621 -1.276 . . . . 0.0 110.99 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 14' ' ' SER . 12.9 p -91.6 32.84 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.865 -1.374 . . . . 0.0 109.446 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' VAL . 3.5 t . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.669 -0.644 . . . . 0.0 109.465 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.9 mttt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 122.052 0.929 . . . . 0.0 108.503 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.413 ' O ' ' CD1' ' A' ' 9' ' ' ILE . 1.1 tt0 -140.29 64.61 1.44 Allowed 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.522 ' O ' ' C ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -73.42 57.17 0.52 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.564 ' CG2' ' N ' ' A' ' 10' ' ' ILE . 2.9 mp -25.07 -94.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.334 0.588 . . . . 0.0 111.04 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.564 ' N ' ' CG2' ' A' ' 9' ' ' ILE . 2.5 mp 54.99 168.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 109.206 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.549 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.1 OUTLIER -80.84 54.23 2.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.333 -0.854 . . . . 0.0 109.211 -179.62 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 14' ' ' SER . . . 76.6 67.94 1.6 Allowed Glycine 0 N--CA 1.482 1.716 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.449 ' HB ' HG22 ' A' ' 10' ' ' ILE . 10.8 p -67.47 40.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 O-C-N 121.956 -0.732 . . . . 0.0 111.439 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.428 ' H ' ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.611 0 O-C-N 120.945 -1.097 . . . . 0.0 108.722 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.42 ' HA ' ' HD2' ' A' ' 6' ' ' LYS . 8.9 mmmt . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 121.171 0.51 . . . . 0.0 109.644 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -92.93 30.57 1.57 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.233 -0.917 . . . . 0.0 108.884 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -136.53 39.97 2.62 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.514 HG23 ' N ' ' A' ' 10' ' ' ILE . 17.0 mm -64.81 -102.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.543 -0.723 . . . . 0.0 110.218 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.52 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 2.9 mp 56.54 168.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.089 -1.007 . . . . 0.0 109.426 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.52 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 6.4 m-85 -78.0 51.43 0.97 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.303 -0.873 . . . . 0.0 109.458 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.17 -90.25 0.02 OUTLIER Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.554 ' CG1' ' O ' ' A' ' 13' ' ' VAL . 0.7 OUTLIER -125.39 14.87 4.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.602 -0.94 . . . . 0.0 109.981 -179.466 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.288 -2.082 0 O-C-N 121.469 -0.769 . . . . 0.0 110.068 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.529 ' HG2' ' CD1' ' A' ' 9' ' ' ILE . 56.0 tt0 -74.47 50.47 0.42 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.495 -0.753 . . . . 0.0 109.316 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.487 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.4 OUTLIER -87.16 50.36 2.0 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.589 -0.694 . . . . 0.0 109.854 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.575 ' CG2' ' N ' ' A' ' 10' ' ' ILE . 2.9 mp -43.67 168.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.32 -0.863 . . . . 0.0 108.939 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.575 ' N ' ' CG2' ' A' ' 9' ' ' ILE . 1.8 mp -55.92 131.64 19.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.688 ' O ' ' CG ' ' A' ' 11' ' ' PHE . 5.2 t80 60.25 26.22 15.68 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.797 1.284 . . . . 0.0 108.024 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.46 -87.72 0.06 OUTLIER Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.537 ' CG1' ' O ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -108.27 20.77 5.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 121.643 -0.916 . . . . 0.0 109.321 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.291 -1.946 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.299 0.571 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -129.9 37.83 3.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.173 -0.954 . . . . 0.0 109.328 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.446 ' OD1' HG12 ' A' ' 10' ' ' ILE . 32.0 t30 -153.46 81.14 1.18 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.521 ' O ' ' O ' ' A' ' 10' ' ' ILE . 1.2 mp -53.55 -17.75 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.259 -0.901 . . . . 0.0 110.728 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.576 ' O ' ' N ' ' A' ' 12' ' ' GLY . 9.6 mm -42.06 166.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.118 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.66 54.6 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.305 -0.872 . . . . 0.0 109.326 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 10' ' ' ILE . . . -83.42 -3.92 89.65 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.465 ' CG2' ' O ' ' A' ' 13' ' ' VAL . 15.0 p -99.7 32.45 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.251 -1.147 . . . . 0.0 110.05 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.295 -1.771 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 47.5 tptt . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 64.9 tt0 178.19 68.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.437 -0.789 . . . . 0.0 109.104 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.484 ' O ' ' C ' ' A' ' 9' ' ' ILE . 1.9 t-20 62.7 95.7 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 11' ' ' PHE . 9.4 mm -24.4 -99.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.264 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.582 ' O ' ' N ' ' A' ' 12' ' ' GLY . 1.9 mp -34.77 92.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.791 -0.568 . . . . 0.0 110.386 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 9' ' ' ILE . 1.1 m-85 18.14 45.45 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 10' ' ' ILE . . . 61.61 9.59 19.4 Favored Glycine 0 N--CA 1.497 2.745 0 C-N-CA 119.772 -1.204 . . . . 0.0 110.729 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' A' ' 10' ' ' ILE . 3.0 p 35.58 31.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.565 -0.962 . . . . 0.0 110.955 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 12' ' ' GLY . 5.0 t . . . . . 0 C--N 1.294 -1.805 0 O-C-N 121.304 -0.873 . . . . 0.0 109.25 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -163.43 58.88 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.801 -1.187 . . . . 0.0 110.262 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -108.49 41.22 1.61 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.107 -0.996 . . . . 0.0 108.737 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.46 ' CD1' ' N ' ' A' ' 9' ' ' ILE . 1.5 mm -86.69 159.36 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-O 121.577 0.703 . . . . 0.0 110.385 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.511 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 4.4 mp -91.18 16.35 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-O 122.224 1.011 . . . . 0.0 108.766 178.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -135.68 22.02 3.35 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -101.25 49.51 1.05 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.515 ' O ' ' HB3' ' A' ' 14' ' ' SER . 11.5 p -80.35 45.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 O-C-N 121.692 -0.887 . . . . 0.0 110.092 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.515 ' HB3' ' O ' ' A' ' 13' ' ' VAL . 2.2 t . . . . . 0 C--N 1.298 -1.646 0 O-C-N 121.547 -0.721 . . . . 0.0 109.751 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.41 ' HE3' ' HB3' ' A' ' 6' ' ' LYS . 13.3 mmmt . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.127 0.489 . . . . 0.0 109.722 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 9' ' ' ILE . 8.7 tt0 -149.07 22.51 0.96 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.142 -0.974 . . . . 0.0 109.719 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.541 ' C ' ' O ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 8.34 59.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.659 0.784 . . . . 0.0 111.966 179.094 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.557 ' N ' ' O ' ' A' ' 7' ' ' GLU . 14.5 mm -50.04 -102.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.731 -0.605 . . . . 0.0 110.143 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.524 ' N ' HG23 ' A' ' 9' ' ' ILE . 3.0 mp 53.72 169.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.116 -0.99 . . . . 0.0 108.822 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.519 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -86.93 49.04 1.74 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.802 -1.186 . . . . 0.0 109.374 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -152.88 12.75 0.63 Allowed Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.103 -1.522 . . . . 0.0 110.884 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' A' ' 14' ' ' SER . 10.9 p -94.21 14.08 2.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.979 -1.307 . . . . 0.0 110.125 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.499 ' HB2' ' O ' ' A' ' 13' ' ' VAL . 2.3 t . . . . . 0 C--N 1.296 -1.747 0 O-C-N 121.797 -0.564 . . . . 0.0 110.764 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.435 ' C ' ' HG3' ' A' ' 7' ' ' GLU . 6.2 tptp . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.438 ' CB ' HD13 ' A' ' 9' ' ' ILE . 22.5 mt-10 66.73 93.17 0.07 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.379 -0.826 . . . . 0.0 109.084 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.455 ' C ' HD11 ' A' ' 10' ' ' ILE . 1.5 p30 -74.14 47.38 0.28 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.493 -0.754 . . . . 0.0 110.244 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.553 ' CG2' ' N ' ' A' ' 10' ' ' ILE . 2.1 mp -44.39 -90.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.112 -0.993 . . . . 0.0 110.094 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.553 ' N ' ' CG2' ' A' ' 9' ' ' ILE . 2.7 mp 61.12 126.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.66 ' O ' ' CG ' ' A' ' 11' ' ' PHE . 4.2 t80 62.74 18.93 11.06 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 122.394 1.092 . . . . 0.0 108.764 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 14' ' ' SER . . . -74.83 -69.55 1.38 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 13' ' ' VAL . 5.7 p 33.57 34.12 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 121.412 0.625 . . . . 0.0 111.266 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 12' ' ' GLY . 2.6 t . . . . . 0 C--N 1.298 -1.638 0 O-C-N 121.364 -0.835 . . . . 0.0 109.795 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -96.91 48.69 1.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.274 -0.891 . . . . 0.0 109.666 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -139.59 58.96 1.6 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.336 -0.852 . . . . 0.0 110.098 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.557 ' CD1' ' N ' ' A' ' 9' ' ' ILE . 3.5 mp -99.93 -115.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.963 -1.086 . . . . 0.0 109.929 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.519 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 2.7 mp 54.03 166.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 O-C-N 121.006 -1.059 . . . . 0.0 109.211 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.519 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 6.2 m-85 -78.02 47.73 0.67 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.107 -0.996 . . . . 0.0 109.623 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.37 4.96 3.81 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.551 ' CG2' ' O ' ' A' ' 13' ' ' VAL . 7.1 p -88.19 36.7 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.324 -1.103 . . . . 0.0 109.41 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 14' ' ' SER . 4.1 t . . . . . 0 C--N 1.297 -1.674 0 O-C-N 121.154 -0.966 . . . . 0.0 108.682 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.503 ' CB ' ' HD3' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 120.551 0.215 . . . . 0.0 110.598 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.503 ' HD3' ' CB ' ' A' ' 1' ' ' MET . 48.2 Cg_endo -79.66 -166.8 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.775 1.408 . . . . 0.0 110.374 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -132.47 -179.01 15.87 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.472 ' O ' HG22 ' A' ' 4' ' ' THR . 11.7 t -93.89 51.44 1.53 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.167 -1.196 . . . . 0.0 109.34 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.534 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 2.3 mt 42.91 86.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-O 121.91 0.862 . . . . 0.0 108.948 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.484 ' HA ' ' CE ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -178.36 90.44 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.719 -0.613 . . . . 0.0 109.584 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 59.59 69.76 0.69 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -0.861 . . . . 0.0 109.595 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.34 54.17 1.2 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.284 -0.885 . . . . 0.0 109.327 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.514 ' O ' ' CG2' ' A' ' 9' ' ' ILE . 1.1 mp -60.23 -14.06 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.207 -0.933 . . . . 0.0 110.266 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.567 ' O ' ' N ' ' A' ' 12' ' ' GLY . 2.8 mm -40.13 161.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.526 ' CD1' ' OH ' ' A' ' 18' ' ' TYR . 74.1 m-85 -66.7 53.66 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.016 -1.053 . . . . 0.0 109.147 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 10' ' ' ILE . . . -145.22 2.22 1.11 Allowed Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.621 -1.276 . . . . 0.0 110.99 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.461 ' O ' ' O ' ' A' ' 14' ' ' SER . 12.9 p -91.6 32.84 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.865 -1.374 . . . . 0.0 109.446 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' VAL . 3.5 t 43.52 94.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.669 -0.644 . . . . 0.0 109.465 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.52 ' O ' ' C ' ' A' ' 16' ' ' ASP . 0.2 OUTLIER -89.72 31.72 0.93 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.111 -0.993 . . . . 0.0 109.84 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.541 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 42.6 t0 29.99 40.95 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.451 0.643 . . . . 0.0 110.126 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 15' ' ' TYR . 53.5 tt0 -159.81 -36.2 0.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.471 -0.768 . . . . 0.0 109.777 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.526 ' OH ' ' CD1' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -45.71 -55.42 6.49 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.449 -0.782 . . . . 0.0 109.542 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -129.06 30.61 5.02 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 121.682 0.754 . . . . 0.0 109.117 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.541 ' CD2' ' HA ' ' A' ' 16' ' ' ASP . 30.1 m-85 -128.86 -12.95 4.71 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.655 -0.653 . . . . 0.0 109.992 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.486 ' HB2' ' HA ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -128.29 52.04 1.93 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.1 -1.0 . . . . 0.0 109.381 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.43 ' C ' HG21 ' A' ' 23' ' ' VAL . 11.4 t 176.36 41.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.386 -0.821 . . . . 0.0 109.237 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.446 HG13 HD13 ' A' ' 24' ' ' ILE . 59.2 t -139.1 -57.72 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.888 . . . . 0.0 109.409 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.446 HD13 HG13 ' A' ' 23' ' ' VAL . 2.4 mp -119.06 43.37 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.203 -0.936 . . . . 0.0 109.537 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.452 ' O ' ' OXT' ' A' ' 26' ' ' ALA . 9.1 ttpt -143.4 47.24 1.49 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.965 . . . . 0.0 109.456 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.452 ' OXT' ' O ' ' A' ' 25' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.638 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -73.27 -59.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.98 1.516 . . . . 0.0 110.52 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 99.03 -159.45 20.1 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.485 ' O ' ' HD2' ' A' ' 6' ' ' LYS . 5.5 t -87.79 52.76 2.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.549 -0.971 . . . . 0.0 109.053 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.448 ' O ' HG21 ' A' ' 5' ' ' ILE . 11.7 mt -71.48 -31.08 41.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.468 -0.77 . . . . 0.0 110.208 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.485 ' HD2' ' O ' ' A' ' 4' ' ' THR . 3.9 mttt 55.89 25.39 8.54 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 122.052 0.929 . . . . 0.0 108.503 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.413 ' O ' ' CD1' ' A' ' 9' ' ' ILE . 1.1 tt0 -140.29 64.61 1.44 Allowed 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.522 ' O ' ' C ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -73.42 57.17 0.52 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.564 ' CG2' ' N ' ' A' ' 10' ' ' ILE . 2.9 mp -25.07 -94.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.334 0.588 . . . . 0.0 111.04 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.564 ' N ' ' CG2' ' A' ' 9' ' ' ILE . 2.5 mp 54.99 168.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 109.206 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.549 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.1 OUTLIER -80.84 54.23 2.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.333 -0.854 . . . . 0.0 109.211 -179.62 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.529 ' O ' ' CZ ' ' A' ' 15' ' ' TYR . . . 76.6 67.94 1.6 Allowed Glycine 0 N--CA 1.482 1.716 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.449 ' HB ' HG22 ' A' ' 10' ' ' ILE . 10.8 p -67.47 40.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 O-C-N 121.956 -0.732 . . . . 0.0 111.439 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.428 ' H ' ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -89.61 37.47 0.87 Allowed 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.945 -1.097 . . . . 0.0 108.722 178.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.529 ' CZ ' ' O ' ' A' ' 12' ' ' GLY . 0.3 OUTLIER -162.16 31.04 0.12 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.586 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 2.7 t70 -161.66 31.62 0.13 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.821 0.819 . . . . 0.0 108.893 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -134.18 -36.8 0.89 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.762 0.792 . . . . 0.0 109.215 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.422 ' CE1' ' HA ' ' A' ' 15' ' ' TYR . 53.5 p90 -97.71 -10.27 25.24 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.749 -0.594 . . . . 0.0 109.79 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.535 ' O ' ' CD1' ' A' ' 20' ' ' TYR . 34.7 ttp180 -120.73 37.22 4.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 109.281 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.586 ' CD1' ' HA ' ' A' ' 16' ' ' ASP . 54.8 m-85 -150.88 -40.13 0.13 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.73 0.776 . . . . 0.0 108.939 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.475 ' O ' ' CB ' ' A' ' 22' ' ' SER . 0.3 OUTLIER -94.98 30.81 2.01 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 25' ' ' LYS . 2.3 p 163.15 59.89 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.465 HG11 HD11 ' A' ' 24' ' ' ILE . 1.6 p -41.73 -28.6 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.422 -0.799 . . . . 0.0 110.12 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.465 HD11 HG11 ' A' ' 23' ' ' VAL . 2.6 mp -105.9 29.39 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.036 -1.04 . . . . 0.0 109.56 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 22' ' ' SER . 0.1 OUTLIER 66.16 -61.4 0.29 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.63 -0.669 . . . . 0.0 109.846 179.451 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 24' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.932 -1.033 . . . . 0.0 109.564 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.529 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 120.713 0.292 . . . . 0.0 110.383 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 1' ' ' MET . 48.8 Cg_endo -77.68 -177.29 3.74 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.915 1.482 . . . . 0.0 110.425 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 83.69 -171.92 49.72 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.2 t -104.94 42.51 1.2 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.349 -1.089 . . . . 0.0 109.756 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.46 HG23 ' HB2' ' A' ' 7' ' ' GLU . 2.2 mp -99.26 -27.39 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -0.883 . . . . 0.0 109.165 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.42 ' HA ' ' HD2' ' A' ' 6' ' ' LYS . 8.9 mmmt 44.0 62.3 2.01 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.704 -0.623 . . . . 0.0 109.644 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.46 ' HB2' HG23 ' A' ' 5' ' ' ILE . 14.4 tt0 -92.93 30.57 1.57 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.233 -0.917 . . . . 0.0 108.884 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -136.53 39.97 2.62 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.514 HG23 ' N ' ' A' ' 10' ' ' ILE . 17.0 mm -64.81 -102.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.543 -0.723 . . . . 0.0 110.218 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.52 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 2.9 mp 56.54 168.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.089 -1.007 . . . . 0.0 109.426 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.52 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 6.4 m-85 -78.0 51.43 0.97 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.303 -0.873 . . . . 0.0 109.458 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.17 -90.25 0.02 OUTLIER Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.575 HG21 ' CD1' ' A' ' 18' ' ' TYR . 0.7 OUTLIER -125.39 14.87 4.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.602 -0.94 . . . . 0.0 109.981 -179.466 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.78 87.83 6.33 Favored 'General case' 0 C--N 1.288 -2.082 0 O-C-N 121.469 -0.769 . . . . 0.0 110.068 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.455 ' O ' ' C ' ' A' ' 16' ' ' ASP . 0.5 OUTLIER -141.52 34.78 1.64 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.263 -0.898 . . . . 0.0 109.079 179.356 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 32.8 t0 38.37 52.46 1.7 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 33.1 tt0 166.93 -22.01 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.305 -0.872 . . . . 0.0 110.077 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.575 ' CD1' HG21 ' A' ' 13' ' ' VAL . 1.3 t80 -99.67 -3.15 33.69 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.166 -0.959 . . . . 0.0 109.299 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.6 ttm180 -91.09 30.48 1.22 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.228 -0.92 . . . . 0.0 108.692 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 53.61 48.64 21.19 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.785 -0.572 . . . . 0.0 109.892 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.463 ' O ' ' HB3' ' A' ' 22' ' ' SER . 0.0 OUTLIER -84.44 45.03 1.08 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.227 -0.921 . . . . 0.0 109.262 179.564 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' A' ' 21' ' ' ARG . 6.7 t 72.16 46.61 0.32 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.137 -0.977 . . . . 0.0 109.43 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.47 HG21 HD13 ' A' ' 24' ' ' ILE . 10.5 p -65.2 -49.94 76.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 O-C-N 121.025 -1.047 . . . . 0.0 109.471 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.518 ' O ' ' C ' ' A' ' 25' ' ' LYS . 3.6 mt -140.53 27.46 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.132 -0.98 . . . . 0.0 108.876 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.518 ' C ' ' O ' ' A' ' 24' ' ' ILE . 15.8 mtmm 26.38 -92.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.326 0.584 . . . . 0.0 110.977 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 24' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.52 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mtt . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 3' ' ' GLY . 50.1 Cg_endo -76.04 51.02 2.99 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.932 1.491 . . . . 0.0 110.164 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.492 ' O ' ' C ' ' A' ' 4' ' ' THR . . . 47.94 -174.95 0.02 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.494 ' O ' HG22 ' A' ' 4' ' ' THR . 7.7 t 34.63 68.32 0.2 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.831 -0.805 . . . . 0.0 110.145 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.4 mp -47.49 -21.59 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.268 -0.895 . . . . 0.0 109.845 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.61 55.4 1.92 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.529 ' HG2' ' CD1' ' A' ' 9' ' ' ILE . 56.0 tt0 -74.47 50.47 0.42 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.495 -0.753 . . . . 0.0 109.316 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.487 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.4 OUTLIER -87.16 50.36 2.0 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.589 -0.694 . . . . 0.0 109.854 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.575 ' CG2' ' N ' ' A' ' 10' ' ' ILE . 2.9 mp -43.67 168.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.32 -0.863 . . . . 0.0 108.939 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.575 ' N ' ' CG2' ' A' ' 9' ' ' ILE . 1.8 mp -55.92 131.64 19.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.688 ' CG ' ' O ' ' A' ' 11' ' ' PHE . 5.2 t80 60.25 26.22 15.68 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.797 1.284 . . . . 0.0 108.024 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.46 -87.72 0.06 OUTLIER Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.537 ' O ' ' CG1' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -108.27 20.77 5.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 121.643 -0.916 . . . . 0.0 109.321 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.539 ' OG ' ' CB ' ' A' ' 18' ' ' TYR . 0.4 OUTLIER -64.88 -96.31 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.536 ' CB ' ' O ' ' A' ' 14' ' ' SER . 0.7 OUTLIER 77.62 75.8 0.07 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.235 -0.916 . . . . 0.0 111.356 178.25 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.479 ' C ' ' O ' ' A' ' 15' ' ' TYR . 19.4 t70 35.27 32.09 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 122.039 0.923 . . . . 0.0 109.765 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -131.68 -29.35 1.73 Allowed 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.553 ' CE2' ' HB3' ' A' ' 21' ' ' ARG . 23.6 t80 -81.58 38.43 0.5 Allowed 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.484 -0.76 . . . . 0.0 110.095 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.512 ' O ' ' HG2' ' A' ' 19' ' ' ARG . 1.3 ttt85 46.58 34.26 2.36 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.916 -1.115 . . . . 0.0 109.003 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.619 ' CD1' ' N ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER 38.86 50.89 1.76 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.63 -0.669 . . . . 0.0 109.91 179.533 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.553 ' HB3' ' CE2' ' A' ' 18' ' ' TYR . 4.3 tpt85 -93.64 51.27 1.55 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.021 -1.049 . . . . 0.0 109.272 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.0 m -135.65 23.92 3.4 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.498 ' O ' HG21 ' A' ' 24' ' ' ILE . 75.6 t -92.64 53.77 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.528 ' CG2' ' O ' ' A' ' 24' ' ' ILE . 3.7 tp 42.39 32.8 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 121.485 0.66 . . . . 0.0 109.51 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER 38.31 46.1 0.87 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.818 -0.551 . . . . 0.0 110.021 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.28 179.843 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.527 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 120.585 0.231 . . . . 0.0 110.459 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 1' ' ' MET . 46.7 Cg_endo -74.09 114.76 4.11 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.886 1.466 . . . . 0.0 110.423 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.467 ' O ' ' CD1' ' A' ' 5' ' ' ILE . . . 165.57 -163.55 36.71 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.477 ' O ' HG13 ' A' ' 5' ' ' ILE . 7.5 t 37.03 61.06 0.93 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.691 -0.888 . . . . 0.0 110.381 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 4' ' ' THR . 5.7 mt -142.33 81.75 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.325 -0.86 . . . . 0.0 109.344 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.32 53.21 1.01 Allowed 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.591 -0.693 . . . . 0.0 109.481 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -129.9 37.83 3.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.173 -0.954 . . . . 0.0 109.328 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.446 ' OD1' HG12 ' A' ' 10' ' ' ILE . 32.0 t30 -153.46 81.14 1.18 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.521 ' O ' ' O ' ' A' ' 10' ' ' ILE . 1.2 mp -53.55 -17.75 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.259 -0.901 . . . . 0.0 110.728 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.576 ' O ' ' N ' ' A' ' 12' ' ' GLY . 9.6 mm -42.06 166.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.118 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.66 54.6 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.305 -0.872 . . . . 0.0 109.326 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' A' ' 10' ' ' ILE . . . -83.42 -3.92 89.65 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.48 ' CG2' ' CD ' ' A' ' 17' ' ' GLU . 15.0 p -99.7 32.45 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.251 -1.147 . . . . 0.0 110.05 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.579 ' O ' ' CD1' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -123.13 23.4 9.22 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.482 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.579 ' CD1' ' O ' ' A' ' 14' ' ' SER . 4.5 m-85 -157.18 24.62 0.31 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.448 ' OD1' ' HA ' ' A' ' 23' ' ' VAL . 3.7 t70 -148.29 25.48 0.99 Allowed 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.48 ' CD ' ' CG2' ' A' ' 13' ' ' VAL . 33.8 mt-10 -141.41 5.54 1.85 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.569 ' CD2' ' O ' ' A' ' 18' ' ' TYR . 69.4 t80 -71.95 0.46 9.25 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.483 ' O ' ' HB2' ' A' ' 20' ' ' TYR . 12.7 ttm180 60.91 24.93 14.93 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.483 ' HB2' ' O ' ' A' ' 19' ' ' ARG . 0.3 OUTLIER 170.54 21.18 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.291 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' A' ' 22' ' ' SER . 5.0 ttp180 -136.86 73.25 1.44 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.603 -1.31 . . . . 0.0 109.281 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 21' ' ' ARG . 0.8 OUTLIER 79.23 39.94 0.1 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.566 -0.709 . . . . 0.0 109.15 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.448 ' HA ' ' OD1' ' A' ' 16' ' ' ASP . 2.4 t -100.28 -52.43 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.519 ' CG2' ' O ' ' A' ' 24' ' ' ILE . 32.2 mm -103.87 32.87 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.346 -0.846 . . . . 0.0 108.981 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.456 ' O ' ' HB3' ' A' ' 26' ' ' ALA . 1.5 tptt -179.3 102.05 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 25' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.492 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 120.759 0.314 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.52 86.64 1.16 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 124.039 1.547 . . . . 0.0 110.366 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 158.97 177.68 32.27 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.475 ' O ' ' CG2' ' A' ' 4' ' ' THR . 13.5 t -102.95 52.86 0.78 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.276 -1.132 . . . . 0.0 109.521 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.481 ' O ' ' CB ' ' A' ' 6' ' ' LYS . 3.0 mp -79.15 -89.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.351 -0.843 . . . . 0.0 109.748 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 5' ' ' ILE . 47.5 tptt 74.11 45.22 0.22 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.339 -0.851 . . . . 0.0 109.257 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.477 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 64.9 tt0 178.19 68.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.437 -0.789 . . . . 0.0 109.104 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.484 ' O ' ' C ' ' A' ' 9' ' ' ILE . 1.9 t-20 62.7 95.7 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 11' ' ' PHE . 9.4 mm -24.4 -99.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.264 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.582 ' O ' ' N ' ' A' ' 12' ' ' GLY . 1.9 mp -34.77 92.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.791 -0.568 . . . . 0.0 110.386 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 9' ' ' ILE . 1.1 m-85 18.14 45.45 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 10' ' ' ILE . . . 61.61 9.59 19.4 Favored Glycine 0 N--CA 1.497 2.745 0 C-N-CA 119.772 -1.204 . . . . 0.0 110.729 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' A' ' 10' ' ' ILE . 3.0 p 35.58 31.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.565 -0.962 . . . . 0.0 110.955 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 12' ' ' GLY . 5.0 t -95.33 46.97 1.12 Allowed 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.304 -0.873 . . . . 0.0 109.25 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.462 ' O ' ' C ' ' A' ' 16' ' ' ASP . 54.7 m-85 -125.65 52.15 1.67 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.157 -0.965 . . . . 0.0 109.907 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' A' ' 15' ' ' TYR . 32.1 t0 38.3 52.67 1.69 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.584 -0.697 . . . . 0.0 109.88 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 21' ' ' ARG . 0.7 OUTLIER 48.23 59.5 4.24 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.472 -0.767 . . . . 0.0 109.198 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.418 ' O ' ' C ' ' A' ' 19' ' ' ARG . 2.4 t80 62.18 33.24 16.95 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.538 ' O ' ' CB ' ' A' ' 20' ' ' TYR . 4.8 ttt180 41.01 49.92 3.08 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.538 ' CB ' ' O ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER 162.87 -11.9 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.506 -0.877 . . . . 0.0 111.368 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 17' ' ' GLU . 16.5 ttt180 60.44 44.12 12.41 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.738 -1.226 . . . . 0.0 108.862 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 25' ' ' LYS . 0.3 OUTLIER -126.76 48.25 2.2 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.467 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.2 p -47.1 -24.0 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.407 -0.808 . . . . 0.0 109.277 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.581 ' CG2' ' O ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -89.0 16.45 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.231 -0.918 . . . . 0.0 109.117 179.697 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 22' ' ' SER . 0.0 OUTLIER 52.85 -113.05 0.74 Allowed 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.424 -0.798 . . . . 0.0 109.482 179.191 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 O-C-N 120.638 -1.289 . . . . 0.0 109.395 -179.977 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.454 ' HB3' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 120.754 0.311 . . . . 0.0 110.186 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 1' ' ' MET . 47.0 Cg_endo -73.21 170.84 18.9 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.045 1.55 . . . . 0.0 110.494 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 172.26 -167.69 40.67 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.529 ' O ' ' C ' ' A' ' 5' ' ' ILE . 8.6 t -83.36 47.05 1.2 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.138 -1.213 . . . . 0.0 109.447 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.581 ' O ' ' HB2' ' A' ' 6' ' ' LYS . 2.2 mt 25.92 67.13 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 121.672 0.749 . . . . 0.0 110.624 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.581 ' HB2' ' O ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER 165.05 52.3 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -163.43 58.88 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.801 -1.187 . . . . 0.0 110.262 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -108.49 41.22 1.61 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.107 -0.996 . . . . 0.0 108.737 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.46 ' CD1' ' N ' ' A' ' 9' ' ' ILE . 1.5 mm -86.69 159.36 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-O 121.577 0.703 . . . . 0.0 110.385 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.511 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 4.4 mp -91.18 16.35 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-O 122.224 1.011 . . . . 0.0 108.766 178.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -135.68 22.02 3.35 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -101.25 49.51 1.05 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.515 ' O ' ' HB3' ' A' ' 14' ' ' SER . 11.5 p -80.35 45.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 O-C-N 121.692 -0.887 . . . . 0.0 110.092 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.515 ' HB3' ' O ' ' A' ' 13' ' ' VAL . 2.2 t 65.59 73.84 0.39 Allowed 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.547 -0.721 . . . . 0.0 109.751 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.422 ' O ' ' C ' ' A' ' 16' ' ' ASP . 0.1 OUTLIER -133.97 51.83 2.1 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.681 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 16' ' ' ASP . 8.6 t0 43.49 60.8 2.47 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.441 -0.787 . . . . 0.0 109.485 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.465 ' C ' ' CG ' ' A' ' 18' ' ' TYR . 7.1 mt-10 46.89 63.68 1.84 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.339 -0.851 . . . . 0.0 109.416 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.479 ' O ' ' C ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER 44.56 51.88 7.82 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.413 -0.804 . . . . 0.0 109.016 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.509 ' O ' ' HG2' ' A' ' 19' ' ' ARG . 8.1 ttt180 39.43 41.65 0.74 Allowed 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.809 0.814 . . . . 0.0 108.822 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.486 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 65.1 t80 57.51 56.52 4.93 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.26 -0.9 . . . . 0.0 108.882 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.406 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 4.8 ttt85 -167.88 90.55 0.31 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.396 -0.815 . . . . 0.0 109.559 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.58 ' O ' ' N ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -87.79 58.39 4.84 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 179.003 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 22' ' ' SER . 13.1 p -37.73 -27.67 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.862 -0.524 . . . . 0.0 110.471 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.527 ' CG2' ' O ' ' A' ' 24' ' ' ILE . 0.7 OUTLIER -87.9 19.25 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 120.998 -1.064 . . . . 0.0 110.071 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.58 ' N ' ' O ' ' A' ' 22' ' ' SER . 1.4 tttt 42.82 -146.52 0.06 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.601 -0.687 . . . . 0.0 109.321 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.446 179.85 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -79.56 45.01 1.83 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.957 1.504 . . . . 0.0 111.129 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 158.08 155.07 7.4 Favored Glycine 0 N--CA 1.491 2.352 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.237 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.565 ' O ' ' CG2' ' A' ' 4' ' ' THR . 8.1 t -125.93 65.11 1.2 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.692 -0.887 . . . . 0.0 109.677 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.6 mt -130.2 77.08 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 120.872 -1.143 . . . . 0.0 109.211 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.41 ' HE3' ' HB3' ' A' ' 6' ' ' LYS . 13.3 mmmt -133.96 57.46 1.81 Allowed 'General case' 0 C--N 1.292 -1.925 0 O-C-N 121.755 -0.591 . . . . 0.0 109.722 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 9' ' ' ILE . 8.7 tt0 -149.07 22.51 0.96 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.142 -0.974 . . . . 0.0 109.719 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.541 ' C ' ' O ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 8.34 59.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.659 0.784 . . . . 0.0 111.966 179.094 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.557 ' N ' ' O ' ' A' ' 7' ' ' GLU . 14.5 mm -50.04 -102.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.731 -0.605 . . . . 0.0 110.143 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.524 ' N ' HG23 ' A' ' 9' ' ' ILE . 3.0 mp 53.72 169.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.116 -0.99 . . . . 0.0 108.822 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.519 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 0.3 OUTLIER -86.93 49.04 1.74 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.802 -1.186 . . . . 0.0 109.374 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.447 ' HA2' ' HB3' ' A' ' 16' ' ' ASP . . . -152.88 12.75 0.63 Allowed Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.103 -1.522 . . . . 0.0 110.884 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' A' ' 14' ' ' SER . 10.9 p -94.21 14.08 2.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.979 -1.307 . . . . 0.0 110.125 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.521 ' C ' ' CG ' ' A' ' 15' ' ' TYR . 2.3 t 175.96 24.86 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.797 -0.564 . . . . 0.0 110.764 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.592 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -172.72 29.89 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.853 -1.154 . . . . 0.0 109.389 179.811 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.447 ' HB3' ' HA2' ' A' ' 12' ' ' GLY . 29.7 t0 -163.52 24.09 0.08 Allowed 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.764 0.792 . . . . 0.0 109.077 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -138.06 6.76 2.64 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -86.85 14.69 6.81 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.479 ' O ' ' HG2' ' A' ' 19' ' ' ARG . 20.0 ttt180 50.15 33.51 7.21 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.561 ' CD1' ' N ' ' A' ' 20' ' ' TYR . 12.7 m-85 40.89 57.47 2.71 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.616 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.495 ' O ' ' CB ' ' A' ' 22' ' ' SER . 8.6 ttp85 -92.96 41.85 1.09 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.52 -0.737 . . . . 0.0 109.507 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.495 ' CB ' ' O ' ' A' ' 21' ' ' ARG . 0.4 OUTLIER 165.28 39.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.327 -0.858 . . . . 0.0 109.714 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.8 t -136.04 -58.81 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.326 -0.859 . . . . 0.0 108.993 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.559 ' CG2' ' O ' ' A' ' 24' ' ' ILE . 2.2 tp -88.03 31.71 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.351 -0.843 . . . . 0.0 109.735 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -156.59 151.84 26.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 0.0 109.447 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.153 -0.967 . . . . 0.0 109.498 -179.972 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 tpp . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.771 0.32 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.19 58.34 4.27 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.978 1.515 . . . . 0.0 110.371 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.481 ' O ' ' CG2' ' A' ' 4' ' ' THR . . . -142.79 -178.32 18.59 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.481 ' CG2' ' O ' ' A' ' 3' ' ' GLY . 9.5 t 37.36 48.4 0.83 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.735 -0.862 . . . . 0.0 110.191 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 4' ' ' THR . 7.8 mt -142.76 81.07 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.414 -0.804 . . . . 0.0 109.055 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.435 ' C ' ' HG3' ' A' ' 7' ' ' GLU . 6.2 tptp -148.93 79.25 1.41 Allowed 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.438 ' CB ' HD13 ' A' ' 9' ' ' ILE . 22.5 mt-10 66.73 93.17 0.07 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.379 -0.826 . . . . 0.0 109.084 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.455 ' C ' HD11 ' A' ' 10' ' ' ILE . 1.5 p30 -74.14 47.38 0.28 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.493 -0.754 . . . . 0.0 110.244 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.553 ' CG2' ' N ' ' A' ' 10' ' ' ILE . 2.1 mp -44.39 -90.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.112 -0.993 . . . . 0.0 110.094 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.553 ' N ' ' CG2' ' A' ' 9' ' ' ILE . 2.7 mp 61.12 126.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.66 ' CG ' ' O ' ' A' ' 11' ' ' PHE . 4.2 t80 62.74 18.93 11.06 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 122.394 1.092 . . . . 0.0 108.764 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 14' ' ' SER . . . -74.83 -69.55 1.38 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.522 ' O ' ' N ' ' A' ' 15' ' ' TYR . 5.7 p 33.57 34.12 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 121.412 0.625 . . . . 0.0 111.266 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 12' ' ' GLY . 2.6 t 61.38 -76.46 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.364 -0.835 . . . . 0.0 109.795 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.544 ' CG ' ' O ' ' A' ' 15' ' ' TYR . 27.5 t80 56.02 25.83 9.28 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.237 -0.914 . . . . 0.0 108.777 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -168.5 27.78 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.645 0.736 . . . . 0.0 109.285 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -139.43 3.3 2.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.553 -0.717 . . . . 0.0 110.094 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -145.19 -37.99 0.27 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.937 -1.102 . . . . 0.0 109.818 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.3 ttm180 -106.53 36.14 2.72 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.655 0.74 . . . . 0.0 109.04 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -119.43 -4.39 10.39 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.65 58.43 1.7 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.273 -0.892 . . . . 0.0 109.396 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.492 ' HA ' ' HB2' ' A' ' 25' ' ' LYS . 1.9 p -152.95 31.72 0.49 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.296 -0.878 . . . . 0.0 108.657 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.0 p -56.05 -49.3 76.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.512 ' CG2' ' O ' ' A' ' 24' ' ' ILE . 36.0 mm -110.08 29.11 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.199 -0.938 . . . . 0.0 109.232 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.492 ' HB2' ' HA ' ' A' ' 22' ' ' SER . 11.8 tttp -84.17 122.13 28.42 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.969 -0.693 . . . . 0.0 109.373 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.601 -179.95 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ttp . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 120.793 0.33 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 3' ' ' GLY . 45.0 Cg_endo -73.31 130.95 15.76 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.054 1.555 . . . . 0.0 110.492 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 2' ' ' PRO . . . -55.49 -168.27 0.06 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.474 ' O ' HG13 ' A' ' 5' ' ' ILE . 8.8 t -90.79 37.84 0.93 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.24 -1.153 . . . . 0.0 109.318 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 4' ' ' THR . 5.3 mt -142.42 79.03 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.589 -0.694 . . . . 0.0 109.43 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.473 ' HG2' ' O ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -158.22 45.85 0.33 Allowed 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.549 -0.72 . . . . 0.0 109.455 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -96.91 48.69 1.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.274 -0.891 . . . . 0.0 109.666 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -139.59 58.96 1.6 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.336 -0.852 . . . . 0.0 110.098 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.557 ' CD1' ' N ' ' A' ' 9' ' ' ILE . 3.5 mp -99.93 -115.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.963 -1.086 . . . . 0.0 109.929 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.519 ' CG2' ' N ' ' A' ' 11' ' ' PHE . 2.7 mp 54.03 166.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 O-C-N 121.006 -1.059 . . . . 0.0 109.211 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.519 ' N ' ' CG2' ' A' ' 10' ' ' ILE . 6.2 m-85 -78.02 47.73 0.67 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.107 -0.996 . . . . 0.0 109.623 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.37 4.96 3.81 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.551 ' O ' ' CG2' ' A' ' 13' ' ' VAL . 7.1 p -88.19 36.7 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.324 -1.103 . . . . 0.0 109.41 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 18' ' ' TYR . 4.1 t 54.66 37.38 28.07 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.154 -0.966 . . . . 0.0 108.682 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.451 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.4 OUTLIER 45.71 70.46 0.36 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.492 -0.755 . . . . 0.0 109.668 -179.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 16' ' ' ASP . 16.6 t70 39.95 59.81 1.85 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.499 -0.75 . . . . 0.0 110.263 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.481 ' O ' ' N ' ' A' ' 21' ' ' ARG . 2.4 mt-10 62.37 60.79 1.36 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.217 -0.927 . . . . 0.0 109.783 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.562 ' CD2' ' O ' ' A' ' 18' ' ' TYR . 84.5 t80 50.14 53.37 12.96 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.442 -0.787 . . . . 0.0 109.449 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.532 ' C ' ' CG ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER 39.78 63.73 0.98 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.383 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 20' ' ' TYR . 0.3 OUTLIER 69.96 65.54 0.23 Allowed 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.605 -0.684 . . . . 0.0 109.27 -179.548 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.536 ' O ' ' CB ' ' A' ' 22' ' ' SER . 0.3 OUTLIER -64.28 54.24 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.284 0.564 . . . . 0.0 109.873 179.623 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 21' ' ' ARG . 0.7 OUTLIER 80.08 44.63 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.543 -0.723 . . . . 0.0 109.42 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.475 ' O ' HG21 ' A' ' 24' ' ' ILE . 4.5 t -124.08 41.56 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.498 ' CG2' ' O ' ' A' ' 24' ' ' ILE . 8.2 tp 35.77 41.16 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 121.293 0.568 . . . . 0.0 109.983 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.522 ' HG3' ' N ' ' A' ' 26' ' ' ALA . 1.8 pttm 40.75 -163.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.653 -0.655 . . . . 0.0 109.967 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.522 ' N ' ' HG3' ' A' ' 25' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.599 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.489 ' CE ' ' HA ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.299 0.571 . . . . 0.0 109.584 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 59.59 69.76 0.69 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -0.861 . . . . 0.0 109.595 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.34 54.17 1.2 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.284 -0.885 . . . . 0.0 109.327 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.514 ' O ' ' CG2' ' A' ' 9' ' ' ILE . 1.1 mp -60.23 -14.06 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.207 -0.933 . . . . 0.0 110.266 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.672 ' N ' HD13 ' A' ' 10' ' ' ILE . 2.8 mm -40.13 161.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -66.7 53.66 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.016 -1.053 . . . . 0.0 109.147 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 10' ' ' ILE . . . -145.22 2.22 1.11 Allowed Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.621 -1.276 . . . . 0.0 110.99 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 13' ' ' VAL . 12.9 p -91.6 32.84 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.865 -1.374 . . . . 0.0 109.446 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' VAL . 3.5 t . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.669 -0.644 . . . . 0.0 109.465 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.9 mttt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 122.052 0.929 . . . . 0.0 108.503 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.894 ' O ' HD12 ' A' ' 9' ' ' ILE . 1.1 tt0 -140.29 64.61 1.44 Allowed 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.522 ' O ' ' C ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -73.42 57.17 0.52 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.631 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.894 HD12 ' O ' ' A' ' 7' ' ' GLU . 2.9 mp -25.07 -94.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.334 0.588 . . . . 0.0 111.04 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.795 ' N ' HG22 ' A' ' 9' ' ' ILE . 2.5 mp 54.99 168.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 109.206 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.554 ' N ' HG22 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -80.84 54.23 2.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.333 -0.854 . . . . 0.0 109.211 -179.62 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 14' ' ' SER . . . 76.6 67.94 1.6 Allowed Glycine 0 N--CA 1.482 1.716 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 13' ' ' VAL . 10.8 p -67.47 40.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 O-C-N 121.956 -0.732 . . . . 0.0 111.439 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.412 ' H ' ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.611 0 O-C-N 120.945 -1.097 . . . . 0.0 108.722 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 6' ' ' LYS . 8.9 mmmt . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 121.171 0.51 . . . . 0.0 109.644 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -92.93 30.57 1.57 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.233 -0.917 . . . . 0.0 108.884 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -136.53 39.97 2.62 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.533 HG22 ' N ' ' A' ' 10' ' ' ILE . 17.0 mm -64.81 -102.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.543 -0.723 . . . . 0.0 110.218 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.722 ' N ' HD12 ' A' ' 10' ' ' ILE . 2.9 mp 56.54 168.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.089 -1.007 . . . . 0.0 109.426 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.62 ' N ' HG22 ' A' ' 10' ' ' ILE . 6.4 m-85 -78.0 51.43 0.97 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.303 -0.873 . . . . 0.0 109.458 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.17 -90.25 0.02 OUTLIER Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.627 ' O ' HG13 ' A' ' 13' ' ' VAL . 0.7 OUTLIER -125.39 14.87 4.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.602 -0.94 . . . . 0.0 109.981 -179.466 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.288 -2.082 0 O-C-N 121.469 -0.769 . . . . 0.0 110.068 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.555 ' HG2' ' CD1' ' A' ' 9' ' ' ILE . 56.0 tt0 -74.47 50.47 0.42 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.495 -0.753 . . . . 0.0 109.316 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.487 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.4 OUTLIER -87.16 50.36 2.0 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.589 -0.694 . . . . 0.0 109.854 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.701 ' H ' HD12 ' A' ' 9' ' ' ILE . 2.9 mp -43.67 168.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.32 -0.863 . . . . 0.0 108.939 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.61 ' N ' HG22 ' A' ' 9' ' ' ILE . 1.8 mp -55.92 131.64 19.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.688 ' O ' ' CG ' ' A' ' 11' ' ' PHE . 5.2 t80 60.25 26.22 15.68 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.797 1.284 . . . . 0.0 108.024 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.46 -87.72 0.06 OUTLIER Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.726 ' O ' HG13 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -108.27 20.77 5.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 121.643 -0.916 . . . . 0.0 109.321 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.291 -1.946 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.299 0.571 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -129.9 37.83 3.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.173 -0.954 . . . . 0.0 109.328 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.468 ' OD1' HG12 ' A' ' 10' ' ' ILE . 32.0 t30 -153.46 81.14 1.18 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.521 ' O ' ' O ' ' A' ' 10' ' ' ILE . 1.2 mp -53.55 -17.75 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.259 -0.901 . . . . 0.0 110.728 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.601 ' O ' ' N ' ' A' ' 12' ' ' GLY . 9.6 mm -42.06 166.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.118 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.454 ' N ' HG22 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -65.66 54.6 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.305 -0.872 . . . . 0.0 109.326 -179.7 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 10' ' ' ILE . . . -83.42 -3.92 89.65 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.748 HG22 ' O ' ' A' ' 13' ' ' VAL . 15.0 p -99.7 32.45 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.251 -1.147 . . . . 0.0 110.05 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.295 -1.771 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 47.5 tptt . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.484 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 64.9 tt0 178.19 68.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.437 -0.789 . . . . 0.0 109.104 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.494 ' HB3' ' HA2' ' A' ' 12' ' ' GLY . 1.9 t-20 62.7 95.7 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.764 HG22 ' N ' ' A' ' 10' ' ' ILE . 9.4 mm -24.4 -99.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.264 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.764 ' N ' HG22 ' A' ' 9' ' ' ILE . 1.9 mp -34.77 92.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.791 -0.568 . . . . 0.0 110.386 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 9' ' ' ILE . 1.1 m-85 18.14 45.45 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 10' ' ' ILE . . . 61.61 9.59 19.4 Favored Glycine 0 N--CA 1.497 2.745 0 C-N-CA 119.772 -1.204 . . . . 0.0 110.729 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.558 ' O ' HG13 ' A' ' 13' ' ' VAL . 3.0 p 35.58 31.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.565 -0.962 . . . . 0.0 110.955 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 12' ' ' GLY . 5.0 t . . . . . 0 C--N 1.294 -1.805 0 O-C-N 121.304 -0.873 . . . . 0.0 109.25 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -163.43 58.88 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.801 -1.187 . . . . 0.0 110.262 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.413 ' C ' HD13 ' A' ' 9' ' ' ILE . 1.4 t-20 -108.49 41.22 1.61 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.107 -0.996 . . . . 0.0 108.737 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.705 ' N ' HD13 ' A' ' 9' ' ' ILE . 1.5 mm -86.69 159.36 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-O 121.577 0.703 . . . . 0.0 110.385 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.749 HG22 ' O ' ' A' ' 10' ' ' ILE . 4.4 mp -91.18 16.35 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-O 122.224 1.011 . . . . 0.0 108.766 178.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -135.68 22.02 3.35 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -101.25 49.51 1.05 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.703 HG22 ' O ' ' A' ' 13' ' ' VAL . 11.5 p -80.35 45.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 O-C-N 121.692 -0.887 . . . . 0.0 110.092 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.512 ' HB3' ' O ' ' A' ' 13' ' ' VAL . 2.2 t . . . . . 0 C--N 1.298 -1.646 0 O-C-N 121.547 -0.721 . . . . 0.0 109.751 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.423 ' HE3' ' HB3' ' A' ' 6' ' ' LYS . 13.3 mmmt . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.127 0.489 . . . . 0.0 109.722 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 9' ' ' ILE . 8.7 tt0 -149.07 22.51 0.96 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.142 -0.974 . . . . 0.0 109.719 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.541 ' C ' ' O ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 8.34 59.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.659 0.784 . . . . 0.0 111.966 179.094 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 10' ' ' ILE . 14.5 mm -50.04 -102.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.731 -0.605 . . . . 0.0 110.143 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.661 ' N ' HD12 ' A' ' 10' ' ' ILE . 3.0 mp 53.72 169.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.116 -0.99 . . . . 0.0 108.822 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.602 ' N ' HG22 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -86.93 49.04 1.74 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.802 -1.186 . . . . 0.0 109.374 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -152.88 12.75 0.63 Allowed Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.103 -1.522 . . . . 0.0 110.884 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 13' ' ' VAL . 10.9 p -94.21 14.08 2.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.979 -1.307 . . . . 0.0 110.125 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.499 ' HB2' ' O ' ' A' ' 13' ' ' VAL . 2.3 t . . . . . 0 C--N 1.296 -1.747 0 O-C-N 121.797 -0.564 . . . . 0.0 110.764 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.431 ' C ' ' HG3' ' A' ' 7' ' ' GLU . 6.2 tptp . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.431 ' HG3' ' C ' ' A' ' 6' ' ' LYS . 22.5 mt-10 66.73 93.17 0.07 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.379 -0.826 . . . . 0.0 109.084 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.453 ' O ' ' CG ' ' A' ' 8' ' ' ASN . 1.5 p30 -74.14 47.38 0.28 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.493 -0.754 . . . . 0.0 110.244 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.803 HG22 ' N ' ' A' ' 10' ' ' ILE . 2.1 mp -44.39 -90.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.112 -0.993 . . . . 0.0 110.094 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.803 ' N ' HG22 ' A' ' 9' ' ' ILE . 2.7 mp 61.12 126.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.66 ' O ' ' CG ' ' A' ' 11' ' ' PHE . 4.2 t80 62.74 18.93 11.06 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 122.394 1.092 . . . . 0.0 108.764 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 14' ' ' SER . . . -74.83 -69.55 1.38 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.515 ' O ' HG13 ' A' ' 13' ' ' VAL . 5.7 p 33.57 34.12 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 121.412 0.625 . . . . 0.0 111.266 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 12' ' ' GLY . 2.6 t . . . . . 0 C--N 1.298 -1.638 0 O-C-N 121.364 -0.835 . . . . 0.0 109.795 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.452 ' O ' HD11 ' A' ' 9' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -96.91 48.69 1.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.274 -0.891 . . . . 0.0 109.666 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -139.59 58.96 1.6 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.336 -0.852 . . . . 0.0 110.098 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.827 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.5 mp -99.93 -115.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.963 -1.086 . . . . 0.0 109.929 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.648 ' N ' HD12 ' A' ' 10' ' ' ILE . 2.7 mp 54.03 166.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 O-C-N 121.006 -1.059 . . . . 0.0 109.211 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.563 ' N ' HG22 ' A' ' 10' ' ' ILE . 6.2 m-85 -78.02 47.73 0.67 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.107 -0.996 . . . . 0.0 109.623 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.37 4.96 3.81 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.814 HG22 ' O ' ' A' ' 13' ' ' VAL . 7.1 p -88.19 36.7 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.324 -1.103 . . . . 0.0 109.41 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 14' ' ' SER . 4.1 t . . . . . 0 C--N 1.297 -1.674 0 O-C-N 121.154 -0.966 . . . . 0.0 108.682 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.508 ' CB ' ' HD3' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 120.551 0.215 . . . . 0.0 110.598 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.508 ' HD3' ' CB ' ' A' ' 1' ' ' MET . 48.2 Cg_endo -79.66 -166.8 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.775 1.408 . . . . 0.0 110.374 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -132.47 -179.01 15.87 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.566 ' O ' HG23 ' A' ' 4' ' ' THR . 11.7 t -93.89 51.44 1.53 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.167 -1.196 . . . . 0.0 109.34 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.792 HG22 ' O ' ' A' ' 5' ' ' ILE . 2.3 mt 42.91 86.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-O 121.91 0.862 . . . . 0.0 108.948 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.489 ' HA ' ' CE ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -178.36 90.44 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.719 -0.613 . . . . 0.0 109.584 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 59.59 69.76 0.69 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -0.861 . . . . 0.0 109.595 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.34 54.17 1.2 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.284 -0.885 . . . . 0.0 109.327 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.514 ' O ' ' CG2' ' A' ' 9' ' ' ILE . 1.1 mp -60.23 -14.06 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.207 -0.933 . . . . 0.0 110.266 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.672 ' N ' HD13 ' A' ' 10' ' ' ILE . 2.8 mm -40.13 161.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.488 ' CD1' ' OH ' ' A' ' 18' ' ' TYR . 74.1 m-85 -66.7 53.66 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.016 -1.053 . . . . 0.0 109.147 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 10' ' ' ILE . . . -145.22 2.22 1.11 Allowed Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.621 -1.276 . . . . 0.0 110.99 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 13' ' ' VAL . 12.9 p -91.6 32.84 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.865 -1.374 . . . . 0.0 109.446 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' VAL . 3.5 t 43.52 94.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.669 -0.644 . . . . 0.0 109.465 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.52 ' O ' ' C ' ' A' ' 16' ' ' ASP . 0.2 OUTLIER -89.72 31.72 0.93 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.111 -0.993 . . . . 0.0 109.84 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.553 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 42.6 t0 29.99 40.95 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.451 0.643 . . . . 0.0 110.126 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.518 ' HA ' ' HB2' ' A' ' 21' ' ' ARG . 53.5 tt0 -159.81 -36.2 0.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.471 -0.768 . . . . 0.0 109.777 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.488 ' OH ' ' CD1' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -45.71 -55.42 6.49 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.449 -0.782 . . . . 0.0 109.542 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -129.06 30.61 5.02 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 121.682 0.754 . . . . 0.0 109.117 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.553 ' CD2' ' HA ' ' A' ' 16' ' ' ASP . 30.1 m-85 -128.86 -12.95 4.71 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.655 -0.653 . . . . 0.0 109.992 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.518 ' HB2' ' HA ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -128.29 52.04 1.93 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.1 -1.0 . . . . 0.0 109.381 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.401 ' O ' ' OG ' ' A' ' 22' ' ' SER . 11.4 t 176.36 41.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.386 -0.821 . . . . 0.0 109.237 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.2 t -139.1 -57.72 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.888 . . . . 0.0 109.409 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.4 mp -119.06 43.37 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.203 -0.936 . . . . 0.0 109.537 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.452 ' O ' ' OXT' ' A' ' 26' ' ' ALA . 9.1 ttpt -143.4 47.24 1.49 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.965 . . . . 0.0 109.456 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.452 ' OXT' ' O ' ' A' ' 25' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.638 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -73.27 -59.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.98 1.516 . . . . 0.0 110.52 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 99.03 -159.45 20.1 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.489 ' O ' ' HD2' ' A' ' 6' ' ' LYS . 5.5 t -87.79 52.76 2.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.549 -0.971 . . . . 0.0 109.053 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.518 HG22 ' HB2' ' A' ' 7' ' ' GLU . 11.7 mt -71.48 -31.08 41.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.468 -0.77 . . . . 0.0 110.208 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.489 ' HD2' ' O ' ' A' ' 4' ' ' THR . 3.9 mttt 55.89 25.39 8.54 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 122.052 0.929 . . . . 0.0 108.503 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.894 ' O ' HD12 ' A' ' 9' ' ' ILE . 1.1 tt0 -140.29 64.61 1.44 Allowed 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.522 ' O ' ' C ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -73.42 57.17 0.52 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.631 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.894 HD12 ' O ' ' A' ' 7' ' ' GLU . 2.9 mp -25.07 -94.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.334 0.588 . . . . 0.0 111.04 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.795 ' N ' HG22 ' A' ' 9' ' ' ILE . 2.5 mp 54.99 168.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 109.206 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.554 ' N ' HG22 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -80.84 54.23 2.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.333 -0.854 . . . . 0.0 109.211 -179.62 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.529 ' O ' ' CZ ' ' A' ' 15' ' ' TYR . . . 76.6 67.94 1.6 Allowed Glycine 0 N--CA 1.482 1.716 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 13' ' ' VAL . 10.8 p -67.47 40.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 O-C-N 121.956 -0.732 . . . . 0.0 111.439 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.412 ' H ' ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -89.61 37.47 0.87 Allowed 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.945 -1.097 . . . . 0.0 108.722 178.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.529 ' CZ ' ' O ' ' A' ' 12' ' ' GLY . 0.3 OUTLIER -162.16 31.04 0.12 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.595 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 2.7 t70 -161.66 31.62 0.13 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.821 0.819 . . . . 0.0 108.893 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -134.18 -36.8 0.89 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.762 0.792 . . . . 0.0 109.215 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.423 ' CE1' ' HA ' ' A' ' 15' ' ' TYR . 53.5 p90 -97.71 -10.27 25.24 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.749 -0.594 . . . . 0.0 109.79 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.535 ' O ' ' CD1' ' A' ' 20' ' ' TYR . 34.7 ttp180 -120.73 37.22 4.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 109.281 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.595 ' CD1' ' HA ' ' A' ' 16' ' ' ASP . 54.8 m-85 -150.88 -40.13 0.13 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.73 0.776 . . . . 0.0 108.939 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.475 ' O ' ' CB ' ' A' ' 22' ' ' SER . 0.3 OUTLIER -94.98 30.81 2.01 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.933 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 25' ' ' LYS . 2.3 p 163.15 59.89 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.725 HG13 ' CD1' ' A' ' 24' ' ' ILE . 1.6 p -41.73 -28.6 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.422 -0.799 . . . . 0.0 110.12 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.725 ' CD1' HG13 ' A' ' 23' ' ' VAL . 2.6 mp -105.9 29.39 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.036 -1.04 . . . . 0.0 109.56 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 22' ' ' SER . 0.1 OUTLIER 66.16 -61.4 0.29 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.63 -0.669 . . . . 0.0 109.846 179.451 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 24' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.932 -1.033 . . . . 0.0 109.564 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.549 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 120.713 0.292 . . . . 0.0 110.383 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 1' ' ' MET . 48.8 Cg_endo -77.68 -177.29 3.74 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.915 1.482 . . . . 0.0 110.425 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 83.69 -171.92 49.72 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.643 ' O ' HG23 ' A' ' 4' ' ' THR . 11.2 t -104.94 42.51 1.2 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.349 -1.089 . . . . 0.0 109.756 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.2 mp -99.26 -27.39 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -0.883 . . . . 0.0 109.165 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 6' ' ' LYS . 8.9 mmmt 44.0 62.3 2.01 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.704 -0.623 . . . . 0.0 109.644 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -92.93 30.57 1.57 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.233 -0.917 . . . . 0.0 108.884 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -136.53 39.97 2.62 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.533 HG22 ' N ' ' A' ' 10' ' ' ILE . 17.0 mm -64.81 -102.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.543 -0.723 . . . . 0.0 110.218 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.722 HD12 ' N ' ' A' ' 10' ' ' ILE . 2.9 mp 56.54 168.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.089 -1.007 . . . . 0.0 109.426 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.62 ' N ' HG22 ' A' ' 10' ' ' ILE . 6.4 m-85 -78.0 51.43 0.97 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.303 -0.873 . . . . 0.0 109.458 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.17 -90.25 0.02 OUTLIER Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.737 HG22 ' CD1' ' A' ' 18' ' ' TYR . 0.7 OUTLIER -125.39 14.87 4.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.602 -0.94 . . . . 0.0 109.981 -179.466 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.78 87.83 6.33 Favored 'General case' 0 C--N 1.288 -2.082 0 O-C-N 121.469 -0.769 . . . . 0.0 110.068 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.455 ' O ' ' C ' ' A' ' 16' ' ' ASP . 0.5 OUTLIER -141.52 34.78 1.64 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.263 -0.898 . . . . 0.0 109.079 179.356 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.502 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 32.8 t0 38.37 52.46 1.7 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 33.1 tt0 166.93 -22.01 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.305 -0.872 . . . . 0.0 110.077 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.737 ' CD1' HG22 ' A' ' 13' ' ' VAL . 1.3 t80 -99.67 -3.15 33.69 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.166 -0.959 . . . . 0.0 109.299 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.6 ttm180 -91.09 30.48 1.22 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.228 -0.92 . . . . 0.0 108.692 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 53.61 48.64 21.19 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.785 -0.572 . . . . 0.0 109.892 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.464 ' O ' ' HB3' ' A' ' 22' ' ' SER . 0.0 OUTLIER -84.44 45.03 1.08 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.227 -0.921 . . . . 0.0 109.262 179.564 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 21' ' ' ARG . 6.7 t 72.16 46.61 0.32 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.137 -0.977 . . . . 0.0 109.43 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.614 HG13 ' N ' ' A' ' 24' ' ' ILE . 10.5 p -65.2 -49.94 76.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 O-C-N 121.025 -1.047 . . . . 0.0 109.471 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.78 HG22 ' O ' ' A' ' 24' ' ' ILE . 3.6 mt -140.53 27.46 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.132 -0.98 . . . . 0.0 108.876 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.518 ' C ' ' O ' ' A' ' 24' ' ' ILE . 15.8 mtmm 26.38 -92.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.326 0.584 . . . . 0.0 110.977 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 24' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.52 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mtt . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 3' ' ' GLY . 50.1 Cg_endo -76.04 51.02 2.99 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.932 1.491 . . . . 0.0 110.164 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.492 ' O ' ' C ' ' A' ' 4' ' ' THR . . . 47.94 -174.95 0.02 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.528 ' O ' HG23 ' A' ' 4' ' ' THR . 7.7 t 34.63 68.32 0.2 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.831 -0.805 . . . . 0.0 110.145 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.4 mp -47.49 -21.59 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.268 -0.895 . . . . 0.0 109.845 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.61 55.4 1.92 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.555 ' HG2' ' CD1' ' A' ' 9' ' ' ILE . 56.0 tt0 -74.47 50.47 0.42 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.495 -0.753 . . . . 0.0 109.316 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.487 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.4 OUTLIER -87.16 50.36 2.0 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.589 -0.694 . . . . 0.0 109.854 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.701 ' H ' HD12 ' A' ' 9' ' ' ILE . 2.9 mp -43.67 168.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.32 -0.863 . . . . 0.0 108.939 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.61 ' N ' HG22 ' A' ' 9' ' ' ILE . 1.8 mp -55.92 131.64 19.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.688 ' CG ' ' O ' ' A' ' 11' ' ' PHE . 5.2 t80 60.25 26.22 15.68 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.797 1.284 . . . . 0.0 108.024 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.46 -87.72 0.06 OUTLIER Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.726 ' O ' HG13 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -108.27 20.77 5.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 121.643 -0.916 . . . . 0.0 109.321 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.539 ' OG ' ' CB ' ' A' ' 18' ' ' TYR . 0.4 OUTLIER -64.88 -96.31 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.536 ' CB ' ' O ' ' A' ' 14' ' ' SER . 0.7 OUTLIER 77.62 75.8 0.07 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.235 -0.916 . . . . 0.0 111.356 178.25 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.479 ' C ' ' O ' ' A' ' 15' ' ' TYR . 19.4 t70 35.27 32.09 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 122.039 0.923 . . . . 0.0 109.765 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -131.68 -29.35 1.73 Allowed 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.577 ' CE2' ' HB3' ' A' ' 21' ' ' ARG . 23.6 t80 -81.58 38.43 0.5 Allowed 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.484 -0.76 . . . . 0.0 110.095 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.525 ' O ' ' HG2' ' A' ' 19' ' ' ARG . 1.3 ttt85 46.58 34.26 2.36 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.916 -1.115 . . . . 0.0 109.003 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.619 ' CD1' ' N ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER 38.86 50.89 1.76 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.63 -0.669 . . . . 0.0 109.91 179.533 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.577 ' HB3' ' CE2' ' A' ' 18' ' ' TYR . 4.3 tpt85 -93.64 51.27 1.55 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.021 -1.049 . . . . 0.0 109.272 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.0 m -135.65 23.92 3.4 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.618 ' O ' HG12 ' A' ' 23' ' ' VAL . 75.6 t -92.64 53.77 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.747 ' O ' HG23 ' A' ' 24' ' ' ILE . 3.7 tp 42.39 32.8 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 121.485 0.66 . . . . 0.0 109.51 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER 38.31 46.1 0.87 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.818 -0.551 . . . . 0.0 110.021 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.28 179.843 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.543 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 120.585 0.231 . . . . 0.0 110.459 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 1' ' ' MET . 46.7 Cg_endo -74.09 114.76 4.11 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.886 1.466 . . . . 0.0 110.423 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.495 ' C ' HG22 ' A' ' 4' ' ' THR . . . 165.57 -163.55 36.71 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.495 HG22 ' C ' ' A' ' 3' ' ' GLY . 7.5 t 37.03 61.06 0.93 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.691 -0.888 . . . . 0.0 110.381 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.538 HG22 ' O ' ' A' ' 5' ' ' ILE . 5.7 mt -142.33 81.75 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.325 -0.86 . . . . 0.0 109.344 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.32 53.21 1.01 Allowed 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.591 -0.693 . . . . 0.0 109.481 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -129.9 37.83 3.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.173 -0.954 . . . . 0.0 109.328 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.468 ' OD1' HG12 ' A' ' 10' ' ' ILE . 32.0 t30 -153.46 81.14 1.18 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.521 ' O ' ' O ' ' A' ' 10' ' ' ILE . 1.2 mp -53.55 -17.75 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.259 -0.901 . . . . 0.0 110.728 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.601 ' O ' ' N ' ' A' ' 12' ' ' GLY . 9.6 mm -42.06 166.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.118 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.454 ' N ' HG22 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -65.66 54.6 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.305 -0.872 . . . . 0.0 109.326 -179.7 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 10' ' ' ILE . . . -83.42 -3.92 89.65 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.748 HG22 ' O ' ' A' ' 13' ' ' VAL . 15.0 p -99.7 32.45 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.251 -1.147 . . . . 0.0 110.05 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.579 ' O ' ' CD1' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -123.13 23.4 9.22 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.482 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.579 ' CD1' ' O ' ' A' ' 14' ' ' SER . 4.5 m-85 -157.18 24.62 0.31 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.458 ' OD1' ' HA ' ' A' ' 23' ' ' VAL . 3.7 t70 -148.29 25.48 0.99 Allowed 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.696 ' OE1' HG22 ' A' ' 13' ' ' VAL . 33.8 mt-10 -141.41 5.54 1.85 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.569 ' CD2' ' O ' ' A' ' 18' ' ' TYR . 69.4 t80 -71.95 0.46 9.25 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 20' ' ' TYR . 12.7 ttm180 60.91 24.93 14.93 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.471 ' HB2' ' O ' ' A' ' 19' ' ' ARG . 0.3 OUTLIER 170.54 21.18 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.291 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' A' ' 22' ' ' SER . 5.0 ttp180 -136.86 73.25 1.44 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.603 -1.31 . . . . 0.0 109.281 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 21' ' ' ARG . 0.8 OUTLIER 79.23 39.94 0.1 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.566 -0.709 . . . . 0.0 109.15 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.458 ' HA ' ' OD1' ' A' ' 16' ' ' ASP . 2.4 t -100.28 -52.43 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.786 HG22 ' O ' ' A' ' 24' ' ' ILE . 32.2 mm -103.87 32.87 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.346 -0.846 . . . . 0.0 108.981 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.521 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 1.5 tptt -179.3 102.05 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.521 ' HB2' ' O ' ' A' ' 25' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.492 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 120.759 0.314 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.52 86.64 1.16 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 124.039 1.547 . . . . 0.0 110.366 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 158.97 177.68 32.27 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.752 ' O ' HG23 ' A' ' 4' ' ' THR . 13.5 t -102.95 52.86 0.78 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.276 -1.132 . . . . 0.0 109.521 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.49 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 3.0 mp -79.15 -89.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.351 -0.843 . . . . 0.0 109.748 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 5' ' ' ILE . 47.5 tptt 74.11 45.22 0.22 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.339 -0.851 . . . . 0.0 109.257 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.484 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 64.9 tt0 178.19 68.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.437 -0.789 . . . . 0.0 109.104 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.494 ' HB3' ' HA2' ' A' ' 12' ' ' GLY . 1.9 t-20 62.7 95.7 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.764 HG22 ' N ' ' A' ' 10' ' ' ILE . 9.4 mm -24.4 -99.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.264 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.764 ' N ' HG22 ' A' ' 9' ' ' ILE . 1.9 mp -34.77 92.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.791 -0.568 . . . . 0.0 110.386 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 9' ' ' ILE . 1.1 m-85 18.14 45.45 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 10' ' ' ILE . . . 61.61 9.59 19.4 Favored Glycine 0 N--CA 1.497 2.745 0 C-N-CA 119.772 -1.204 . . . . 0.0 110.729 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.558 ' O ' HG13 ' A' ' 13' ' ' VAL . 3.0 p 35.58 31.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.565 -0.962 . . . . 0.0 110.955 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 12' ' ' GLY . 5.0 t -95.33 46.97 1.12 Allowed 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.304 -0.873 . . . . 0.0 109.25 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.462 ' O ' ' C ' ' A' ' 16' ' ' ASP . 54.7 m-85 -125.65 52.15 1.67 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.157 -0.965 . . . . 0.0 109.907 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' A' ' 15' ' ' TYR . 32.1 t0 38.3 52.67 1.69 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.584 -0.697 . . . . 0.0 109.88 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 21' ' ' ARG . 0.7 OUTLIER 48.23 59.5 4.24 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.472 -0.767 . . . . 0.0 109.198 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.418 ' O ' ' C ' ' A' ' 19' ' ' ARG . 2.4 t80 62.18 33.24 16.95 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.538 ' O ' ' CB ' ' A' ' 20' ' ' TYR . 4.8 ttt180 41.01 49.92 3.08 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.538 ' CB ' ' O ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER 162.87 -11.9 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.506 -0.877 . . . . 0.0 111.368 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.54 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 16.5 ttt180 60.44 44.12 12.41 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.738 -1.226 . . . . 0.0 108.862 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 25' ' ' LYS . 0.3 OUTLIER -126.76 48.25 2.2 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.467 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.2 p -47.1 -24.0 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.407 -0.808 . . . . 0.0 109.277 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.595 ' O ' HG23 ' A' ' 24' ' ' ILE . 0.1 OUTLIER -89.0 16.45 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.231 -0.918 . . . . 0.0 109.117 179.697 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 22' ' ' SER . 0.0 OUTLIER 52.85 -113.05 0.74 Allowed 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.424 -0.798 . . . . 0.0 109.482 179.191 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 O-C-N 120.638 -1.289 . . . . 0.0 109.395 -179.977 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.432 ' HB3' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 120.754 0.311 . . . . 0.0 110.186 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 1' ' ' MET . 47.0 Cg_endo -73.21 170.84 18.9 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.045 1.55 . . . . 0.0 110.494 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 172.26 -167.69 40.67 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.721 ' O ' HG23 ' A' ' 4' ' ' THR . 8.6 t -83.36 47.05 1.2 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.138 -1.213 . . . . 0.0 109.447 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.849 HG22 ' O ' ' A' ' 5' ' ' ILE . 2.2 mt 25.92 67.13 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 121.672 0.749 . . . . 0.0 110.624 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.583 ' HB2' ' O ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER 165.05 52.3 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -163.43 58.88 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.801 -1.187 . . . . 0.0 110.262 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.413 ' C ' HD13 ' A' ' 9' ' ' ILE . 1.4 t-20 -108.49 41.22 1.61 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.107 -0.996 . . . . 0.0 108.737 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.705 HD13 ' N ' ' A' ' 9' ' ' ILE . 1.5 mm -86.69 159.36 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-O 121.577 0.703 . . . . 0.0 110.385 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.749 HG22 ' O ' ' A' ' 10' ' ' ILE . 4.4 mp -91.18 16.35 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-O 122.224 1.011 . . . . 0.0 108.766 178.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -135.68 22.02 3.35 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -101.25 49.51 1.05 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.703 HG22 ' O ' ' A' ' 13' ' ' VAL . 11.5 p -80.35 45.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 O-C-N 121.692 -0.887 . . . . 0.0 110.092 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.512 ' HB3' ' O ' ' A' ' 13' ' ' VAL . 2.2 t 65.59 73.84 0.39 Allowed 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.547 -0.721 . . . . 0.0 109.751 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.422 ' O ' ' C ' ' A' ' 16' ' ' ASP . 0.1 OUTLIER -133.97 51.83 2.1 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.681 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 16' ' ' ASP . 8.6 t0 43.49 60.8 2.47 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.441 -0.787 . . . . 0.0 109.485 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.465 ' C ' ' CG ' ' A' ' 18' ' ' TYR . 7.1 mt-10 46.89 63.68 1.84 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.339 -0.851 . . . . 0.0 109.416 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.479 ' O ' ' C ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER 44.56 51.88 7.82 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.413 -0.804 . . . . 0.0 109.016 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.524 ' O ' ' HG2' ' A' ' 19' ' ' ARG . 8.1 ttt180 39.43 41.65 0.74 Allowed 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.809 0.814 . . . . 0.0 108.822 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.486 ' O ' ' CD2' ' A' ' 20' ' ' TYR . 65.1 t80 57.51 56.52 4.93 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.26 -0.9 . . . . 0.0 108.882 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 4.8 ttt85 -167.88 90.55 0.31 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.396 -0.815 . . . . 0.0 109.559 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.58 ' O ' ' N ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -87.79 58.39 4.84 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 179.003 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 22' ' ' SER . 13.1 p -37.73 -27.67 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.862 -0.524 . . . . 0.0 110.471 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.712 ' O ' HG23 ' A' ' 24' ' ' ILE . 0.7 OUTLIER -87.9 19.25 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 120.998 -1.064 . . . . 0.0 110.071 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.58 ' N ' ' O ' ' A' ' 22' ' ' SER . 1.4 tttt 42.82 -146.52 0.06 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.601 -0.687 . . . . 0.0 109.321 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' A' ' 25' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.446 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -79.56 45.01 1.83 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.957 1.504 . . . . 0.0 111.129 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 158.08 155.07 7.4 Favored Glycine 0 N--CA 1.491 2.352 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.237 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.842 ' O ' HG23 ' A' ' 4' ' ' THR . 8.1 t -125.93 65.11 1.2 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.692 -0.887 . . . . 0.0 109.677 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.653 HG22 ' O ' ' A' ' 5' ' ' ILE . 6.6 mt -130.2 77.08 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 120.872 -1.143 . . . . 0.0 109.211 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.423 ' HE3' ' HB3' ' A' ' 6' ' ' LYS . 13.3 mmmt -133.96 57.46 1.81 Allowed 'General case' 0 C--N 1.292 -1.925 0 O-C-N 121.755 -0.591 . . . . 0.0 109.722 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 9' ' ' ILE . 8.7 tt0 -149.07 22.51 0.96 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.142 -0.974 . . . . 0.0 109.719 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.541 ' C ' ' O ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 8.34 59.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.659 0.784 . . . . 0.0 111.966 179.094 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 10' ' ' ILE . 14.5 mm -50.04 -102.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.731 -0.605 . . . . 0.0 110.143 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.661 HD12 ' N ' ' A' ' 10' ' ' ILE . 3.0 mp 53.72 169.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.116 -0.99 . . . . 0.0 108.822 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.602 ' N ' HG22 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -86.93 49.04 1.74 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.802 -1.186 . . . . 0.0 109.374 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.489 ' HA2' ' HB3' ' A' ' 16' ' ' ASP . . . -152.88 12.75 0.63 Allowed Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.103 -1.522 . . . . 0.0 110.884 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 13' ' ' VAL . 10.9 p -94.21 14.08 2.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.979 -1.307 . . . . 0.0 110.125 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.521 ' C ' ' CG ' ' A' ' 15' ' ' TYR . 2.3 t 175.96 24.86 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.797 -0.564 . . . . 0.0 110.764 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.592 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -172.72 29.89 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.853 -1.154 . . . . 0.0 109.389 179.811 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.489 ' HB3' ' HA2' ' A' ' 12' ' ' GLY . 29.7 t0 -163.52 24.09 0.08 Allowed 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.764 0.792 . . . . 0.0 109.077 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -138.06 6.76 2.64 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -86.85 14.69 6.81 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.488 ' O ' ' HG2' ' A' ' 19' ' ' ARG . 20.0 ttt180 50.15 33.51 7.21 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.561 ' CD1' ' N ' ' A' ' 20' ' ' TYR . 12.7 m-85 40.89 57.47 2.71 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.616 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.495 ' O ' ' CB ' ' A' ' 22' ' ' SER . 8.6 ttp85 -92.96 41.85 1.09 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.52 -0.737 . . . . 0.0 109.507 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.495 ' CB ' ' O ' ' A' ' 21' ' ' ARG . 0.4 OUTLIER 165.28 39.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.327 -0.858 . . . . 0.0 109.714 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.8 t -136.04 -58.81 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.326 -0.859 . . . . 0.0 108.993 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.755 ' O ' HG23 ' A' ' 24' ' ' ILE . 2.2 tp -88.03 31.71 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.351 -0.843 . . . . 0.0 109.735 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -156.59 151.84 26.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 0.0 109.447 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.153 -0.967 . . . . 0.0 109.498 -179.972 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 tpp . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.771 0.32 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.19 58.34 4.27 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.978 1.515 . . . . 0.0 110.371 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.534 ' O ' HD12 ' A' ' 5' ' ' ILE . . . -142.79 -178.32 18.59 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.513 HG22 ' C ' ' A' ' 3' ' ' GLY . 9.5 t 37.36 48.4 0.83 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.735 -0.862 . . . . 0.0 110.191 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.545 HG22 ' O ' ' A' ' 5' ' ' ILE . 7.8 mt -142.76 81.07 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.414 -0.804 . . . . 0.0 109.055 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.431 ' C ' ' HG3' ' A' ' 7' ' ' GLU . 6.2 tptp -148.93 79.25 1.41 Allowed 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.431 ' HG3' ' C ' ' A' ' 6' ' ' LYS . 22.5 mt-10 66.73 93.17 0.07 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.379 -0.826 . . . . 0.0 109.084 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.453 ' O ' ' CG ' ' A' ' 8' ' ' ASN . 1.5 p30 -74.14 47.38 0.28 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.493 -0.754 . . . . 0.0 110.244 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.803 HG22 ' N ' ' A' ' 10' ' ' ILE . 2.1 mp -44.39 -90.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.112 -0.993 . . . . 0.0 110.094 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.803 ' N ' HG22 ' A' ' 9' ' ' ILE . 2.7 mp 61.12 126.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.66 ' CG ' ' O ' ' A' ' 11' ' ' PHE . 4.2 t80 62.74 18.93 11.06 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 122.394 1.092 . . . . 0.0 108.764 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 14' ' ' SER . . . -74.83 -69.55 1.38 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.522 ' O ' ' N ' ' A' ' 15' ' ' TYR . 5.7 p 33.57 34.12 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 121.412 0.625 . . . . 0.0 111.266 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 12' ' ' GLY . 2.6 t 61.38 -76.46 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.364 -0.835 . . . . 0.0 109.795 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.544 ' CG ' ' O ' ' A' ' 15' ' ' TYR . 27.5 t80 56.02 25.83 9.28 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.237 -0.914 . . . . 0.0 108.777 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -168.5 27.78 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.645 0.736 . . . . 0.0 109.285 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -139.43 3.3 2.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.553 -0.717 . . . . 0.0 110.094 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -145.19 -37.99 0.27 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.937 -1.102 . . . . 0.0 109.818 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.3 ttm180 -106.53 36.14 2.72 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.655 0.74 . . . . 0.0 109.04 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -119.43 -4.39 10.39 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.65 58.43 1.7 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.273 -0.892 . . . . 0.0 109.396 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.529 ' HA ' ' HB2' ' A' ' 25' ' ' LYS . 1.9 p -152.95 31.72 0.49 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.296 -0.878 . . . . 0.0 108.657 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.467 HG13 ' H ' ' A' ' 24' ' ' ILE . 2.0 p -56.05 -49.3 76.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.78 HG22 ' O ' ' A' ' 24' ' ' ILE . 36.0 mm -110.08 29.11 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.199 -0.938 . . . . 0.0 109.232 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.529 ' HB2' ' HA ' ' A' ' 22' ' ' SER . 11.8 tttp -84.17 122.13 28.42 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.969 -0.693 . . . . 0.0 109.373 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.601 -179.95 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ttp . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 120.793 0.33 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 3' ' ' GLY . 45.0 Cg_endo -73.31 130.95 15.76 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.054 1.555 . . . . 0.0 110.492 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 2' ' ' PRO . . . -55.49 -168.27 0.06 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.484 ' O ' HG13 ' A' ' 5' ' ' ILE . 8.8 t -90.79 37.84 0.93 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.24 -1.153 . . . . 0.0 109.318 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 5' ' ' ILE . 5.3 mt -142.42 79.03 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.589 -0.694 . . . . 0.0 109.43 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -158.22 45.85 0.33 Allowed 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.549 -0.72 . . . . 0.0 109.455 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -96.91 48.69 1.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.274 -0.891 . . . . 0.0 109.666 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -139.59 58.96 1.6 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.336 -0.852 . . . . 0.0 110.098 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.827 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.5 mp -99.93 -115.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.963 -1.086 . . . . 0.0 109.929 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.648 HD12 ' N ' ' A' ' 10' ' ' ILE . 2.7 mp 54.03 166.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 O-C-N 121.006 -1.059 . . . . 0.0 109.211 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.563 ' N ' HG22 ' A' ' 10' ' ' ILE . 6.2 m-85 -78.02 47.73 0.67 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.107 -0.996 . . . . 0.0 109.623 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.37 4.96 3.81 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.814 HG22 ' O ' ' A' ' 13' ' ' VAL . 7.1 p -88.19 36.7 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.324 -1.103 . . . . 0.0 109.41 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 14' ' ' SER . 4.1 t 54.66 37.38 28.07 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.154 -0.966 . . . . 0.0 108.682 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.451 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.4 OUTLIER 45.71 70.46 0.36 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.492 -0.755 . . . . 0.0 109.668 -179.829 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.495 ' H ' HG13 ' A' ' 13' ' ' VAL . 16.6 t70 39.95 59.81 1.85 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.499 -0.75 . . . . 0.0 110.263 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.481 ' O ' ' N ' ' A' ' 21' ' ' ARG . 2.4 mt-10 62.37 60.79 1.36 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.217 -0.927 . . . . 0.0 109.783 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.562 ' CD2' ' O ' ' A' ' 18' ' ' TYR . 84.5 t80 50.14 53.37 12.96 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.442 -0.787 . . . . 0.0 109.449 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.532 ' C ' ' CG ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER 39.78 63.73 0.98 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.383 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 20' ' ' TYR . 0.3 OUTLIER 69.96 65.54 0.23 Allowed 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.605 -0.684 . . . . 0.0 109.27 -179.548 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.536 ' O ' ' CB ' ' A' ' 22' ' ' SER . 0.3 OUTLIER -64.28 54.24 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.284 0.564 . . . . 0.0 109.873 179.623 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 20' ' ' TYR . 0.7 OUTLIER 80.08 44.63 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.543 -0.723 . . . . 0.0 109.42 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.464 ' O ' ' C ' ' A' ' 24' ' ' ILE . 4.5 t -124.08 41.56 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.746 ' O ' HG23 ' A' ' 24' ' ' ILE . 8.2 tp 35.77 41.16 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 121.293 0.568 . . . . 0.0 109.983 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.522 ' HG3' ' N ' ' A' ' 26' ' ' ALA . 1.8 pttm 40.75 -163.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.653 -0.655 . . . . 0.0 109.967 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.522 ' N ' ' HG3' ' A' ' 25' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.599 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.489 ' HA ' ' CE ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.299 0.571 . . . . 0.0 109.584 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 59.59 69.76 0.69 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -0.861 . . . . 0.0 109.595 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.34 54.17 1.2 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.284 -0.885 . . . . 0.0 109.327 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.514 ' O ' ' CG2' ' A' ' 9' ' ' ILE . 1.1 mp -60.23 -14.06 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.207 -0.933 . . . . 0.0 110.266 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.672 ' N ' HD13 ' A' ' 10' ' ' ILE . 2.8 mm -40.13 161.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -66.7 53.66 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.016 -1.053 . . . . 0.0 109.147 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 10' ' ' ILE . . . -145.22 2.22 1.11 Allowed Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.621 -1.276 . . . . 0.0 110.99 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.702 ' O ' HG22 ' A' ' 13' ' ' VAL . 12.9 p -91.6 32.84 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.865 -1.374 . . . . 0.0 109.446 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' VAL . 3.5 t . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.669 -0.644 . . . . 0.0 109.465 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.9 mttt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 122.052 0.929 . . . . 0.0 108.503 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.894 ' O ' HD12 ' A' ' 9' ' ' ILE . 1.1 tt0 -140.29 64.61 1.44 Allowed 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.522 ' O ' ' C ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -73.42 57.17 0.52 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.631 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.894 HD12 ' O ' ' A' ' 7' ' ' GLU . 2.9 mp -25.07 -94.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.334 0.588 . . . . 0.0 111.04 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.795 ' N ' HG22 ' A' ' 9' ' ' ILE . 2.5 mp 54.99 168.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 109.206 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.554 ' N ' HG22 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -80.84 54.23 2.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.333 -0.854 . . . . 0.0 109.211 -179.62 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.412 ' C ' ' H ' ' A' ' 14' ' ' SER . . . 76.6 67.94 1.6 Allowed Glycine 0 N--CA 1.482 1.716 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.636 ' O ' HG22 ' A' ' 13' ' ' VAL . 10.8 p -67.47 40.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 O-C-N 121.956 -0.732 . . . . 0.0 111.439 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.412 ' H ' ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.611 0 O-C-N 120.945 -1.097 . . . . 0.0 108.722 178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 6' ' ' LYS . 8.9 mmmt . . . . . 0 N--CA 1.488 1.445 0 CA-C-O 121.171 0.51 . . . . 0.0 109.644 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -92.93 30.57 1.57 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.233 -0.917 . . . . 0.0 108.884 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -136.53 39.97 2.62 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.533 HG22 ' N ' ' A' ' 10' ' ' ILE . 17.0 mm -64.81 -102.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.543 -0.723 . . . . 0.0 110.218 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.722 HD12 ' N ' ' A' ' 10' ' ' ILE . 2.9 mp 56.54 168.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.089 -1.007 . . . . 0.0 109.426 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.62 ' N ' HG22 ' A' ' 10' ' ' ILE . 6.4 m-85 -78.0 51.43 0.97 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.303 -0.873 . . . . 0.0 109.458 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.17 -90.25 0.02 OUTLIER Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.627 ' O ' HG13 ' A' ' 13' ' ' VAL . 0.7 OUTLIER -125.39 14.87 4.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.602 -0.94 . . . . 0.0 109.981 -179.466 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.288 -2.082 0 O-C-N 121.469 -0.769 . . . . 0.0 110.068 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.555 ' HG2' ' CD1' ' A' ' 9' ' ' ILE . 56.0 tt0 -74.47 50.47 0.42 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.495 -0.753 . . . . 0.0 109.316 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.487 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.4 OUTLIER -87.16 50.36 2.0 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.589 -0.694 . . . . 0.0 109.854 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.701 ' H ' HD12 ' A' ' 9' ' ' ILE . 2.9 mp -43.67 168.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.32 -0.863 . . . . 0.0 108.939 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.61 ' N ' HG22 ' A' ' 9' ' ' ILE . 1.8 mp -55.92 131.64 19.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.688 ' CG ' ' O ' ' A' ' 11' ' ' PHE . 5.2 t80 60.25 26.22 15.68 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.797 1.284 . . . . 0.0 108.024 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.46 -87.72 0.06 OUTLIER Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.726 ' O ' HG13 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -108.27 20.77 5.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 121.643 -0.916 . . . . 0.0 109.321 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.291 -1.946 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.299 0.571 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -129.9 37.83 3.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.173 -0.954 . . . . 0.0 109.328 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.468 ' OD1' HG12 ' A' ' 10' ' ' ILE . 32.0 t30 -153.46 81.14 1.18 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.521 ' O ' ' O ' ' A' ' 10' ' ' ILE . 1.2 mp -53.55 -17.75 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.259 -0.901 . . . . 0.0 110.728 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.601 ' O ' ' N ' ' A' ' 12' ' ' GLY . 9.6 mm -42.06 166.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.118 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.454 ' N ' HG22 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -65.66 54.6 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.305 -0.872 . . . . 0.0 109.326 -179.7 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 10' ' ' ILE . . . -83.42 -3.92 89.65 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.748 ' O ' HG22 ' A' ' 13' ' ' VAL . 15.0 p -99.7 32.45 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.251 -1.147 . . . . 0.0 110.05 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.295 -1.771 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 47.5 tptt . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.484 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 64.9 tt0 178.19 68.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.437 -0.789 . . . . 0.0 109.104 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.494 ' HB3' ' HA2' ' A' ' 12' ' ' GLY . 1.9 t-20 62.7 95.7 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.764 HG22 ' N ' ' A' ' 10' ' ' ILE . 9.4 mm -24.4 -99.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.264 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.764 ' N ' HG22 ' A' ' 9' ' ' ILE . 1.9 mp -34.77 92.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.791 -0.568 . . . . 0.0 110.386 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 9' ' ' ILE . 1.1 m-85 18.14 45.45 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 10' ' ' ILE . . . 61.61 9.59 19.4 Favored Glycine 0 N--CA 1.497 2.745 0 C-N-CA 119.772 -1.204 . . . . 0.0 110.729 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.558 HG13 ' O ' ' A' ' 13' ' ' VAL . 3.0 p 35.58 31.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.565 -0.962 . . . . 0.0 110.955 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 12' ' ' GLY . 5.0 t . . . . . 0 C--N 1.294 -1.805 0 O-C-N 121.304 -0.873 . . . . 0.0 109.25 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -163.43 58.88 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.801 -1.187 . . . . 0.0 110.262 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.413 ' C ' HD13 ' A' ' 9' ' ' ILE . 1.4 t-20 -108.49 41.22 1.61 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.107 -0.996 . . . . 0.0 108.737 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.705 ' N ' HD13 ' A' ' 9' ' ' ILE . 1.5 mm -86.69 159.36 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-O 121.577 0.703 . . . . 0.0 110.385 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.749 ' O ' HG22 ' A' ' 10' ' ' ILE . 4.4 mp -91.18 16.35 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-O 122.224 1.011 . . . . 0.0 108.766 178.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -135.68 22.02 3.35 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -101.25 49.51 1.05 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.703 ' O ' HG22 ' A' ' 13' ' ' VAL . 11.5 p -80.35 45.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 O-C-N 121.692 -0.887 . . . . 0.0 110.092 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.512 ' HB3' ' O ' ' A' ' 13' ' ' VAL . 2.2 t . . . . . 0 C--N 1.298 -1.646 0 O-C-N 121.547 -0.721 . . . . 0.0 109.751 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.423 ' HE3' ' HB3' ' A' ' 6' ' ' LYS . 13.3 mmmt . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.127 0.489 . . . . 0.0 109.722 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 9' ' ' ILE . 8.7 tt0 -149.07 22.51 0.96 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.142 -0.974 . . . . 0.0 109.719 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.541 ' C ' ' O ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 8.34 59.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.659 0.784 . . . . 0.0 111.966 179.094 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 10' ' ' ILE . 14.5 mm -50.04 -102.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.731 -0.605 . . . . 0.0 110.143 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.661 HD12 ' N ' ' A' ' 10' ' ' ILE . 3.0 mp 53.72 169.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.116 -0.99 . . . . 0.0 108.822 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.602 ' N ' HG22 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -86.93 49.04 1.74 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.802 -1.186 . . . . 0.0 109.374 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -152.88 12.75 0.63 Allowed Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.103 -1.522 . . . . 0.0 110.884 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.585 ' O ' HG22 ' A' ' 13' ' ' VAL . 10.9 p -94.21 14.08 2.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.979 -1.307 . . . . 0.0 110.125 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.499 ' HB2' ' O ' ' A' ' 13' ' ' VAL . 2.3 t . . . . . 0 C--N 1.296 -1.747 0 O-C-N 121.797 -0.564 . . . . 0.0 110.764 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.431 ' C ' ' HG3' ' A' ' 7' ' ' GLU . 6.2 tptp . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.431 ' HG3' ' C ' ' A' ' 6' ' ' LYS . 22.5 mt-10 66.73 93.17 0.07 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.379 -0.826 . . . . 0.0 109.084 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.453 ' O ' ' CG ' ' A' ' 8' ' ' ASN . 1.5 p30 -74.14 47.38 0.28 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.493 -0.754 . . . . 0.0 110.244 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.803 HG22 ' N ' ' A' ' 10' ' ' ILE . 2.1 mp -44.39 -90.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.112 -0.993 . . . . 0.0 110.094 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.803 ' N ' HG22 ' A' ' 9' ' ' ILE . 2.7 mp 61.12 126.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.66 ' CG ' ' O ' ' A' ' 11' ' ' PHE . 4.2 t80 62.74 18.93 11.06 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 122.394 1.092 . . . . 0.0 108.764 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 14' ' ' SER . . . -74.83 -69.55 1.38 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.515 ' O ' HG13 ' A' ' 13' ' ' VAL . 5.7 p 33.57 34.12 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 121.412 0.625 . . . . 0.0 111.266 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 12' ' ' GLY . 2.6 t . . . . . 0 C--N 1.298 -1.638 0 O-C-N 121.364 -0.835 . . . . 0.0 109.795 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.452 ' O ' HD11 ' A' ' 9' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -96.91 48.69 1.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.274 -0.891 . . . . 0.0 109.666 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -139.59 58.96 1.6 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.336 -0.852 . . . . 0.0 110.098 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.827 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.5 mp -99.93 -115.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.963 -1.086 . . . . 0.0 109.929 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.648 HD12 ' N ' ' A' ' 10' ' ' ILE . 2.7 mp 54.03 166.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 O-C-N 121.006 -1.059 . . . . 0.0 109.211 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.563 ' N ' HG22 ' A' ' 10' ' ' ILE . 6.2 m-85 -78.02 47.73 0.67 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.107 -0.996 . . . . 0.0 109.623 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.37 4.96 3.81 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.814 ' O ' HG22 ' A' ' 13' ' ' VAL . 7.1 p -88.19 36.7 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.324 -1.103 . . . . 0.0 109.41 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 14' ' ' SER . 4.1 t . . . . . 0 C--N 1.297 -1.674 0 O-C-N 121.154 -0.966 . . . . 0.0 108.682 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.508 ' CB ' ' HD3' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 120.551 0.215 . . . . 0.0 110.598 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.508 ' HD3' ' CB ' ' A' ' 1' ' ' MET . 48.2 Cg_endo -79.66 -166.8 0.44 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.775 1.408 . . . . 0.0 110.374 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -132.47 -179.01 15.87 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 4' ' ' THR . 11.7 t -93.89 51.44 1.53 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.167 -1.196 . . . . 0.0 109.34 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.792 HG22 ' O ' ' A' ' 5' ' ' ILE . 2.3 mt 42.91 86.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 CA-C-O 121.91 0.862 . . . . 0.0 108.948 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.489 ' HA ' ' CE ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -178.36 90.44 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.817 0 O-C-N 121.719 -0.613 . . . . 0.0 109.584 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 59.59 69.76 0.69 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.323 -0.861 . . . . 0.0 109.595 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.34 54.17 1.2 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.284 -0.885 . . . . 0.0 109.327 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.514 ' O ' ' CG2' ' A' ' 9' ' ' ILE . 1.1 mp -60.23 -14.06 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.207 -0.933 . . . . 0.0 110.266 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.672 HD13 ' N ' ' A' ' 10' ' ' ILE . 2.8 mm -40.13 161.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -178.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.488 ' CD1' ' OH ' ' A' ' 18' ' ' TYR . 74.1 m-85 -66.7 53.66 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.016 -1.053 . . . . 0.0 109.147 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 10' ' ' ILE . . . -145.22 2.22 1.11 Allowed Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.621 -1.276 . . . . 0.0 110.99 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 13' ' ' VAL . 12.9 p -91.6 32.84 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 120.865 -1.374 . . . . 0.0 109.446 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' VAL . 3.5 t 43.52 94.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.669 -0.644 . . . . 0.0 109.465 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.52 ' O ' ' C ' ' A' ' 16' ' ' ASP . 0.2 OUTLIER -89.72 31.72 0.93 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.111 -0.993 . . . . 0.0 109.84 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.553 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 42.6 t0 29.99 40.95 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.451 0.643 . . . . 0.0 110.126 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.518 ' HA ' ' HB2' ' A' ' 21' ' ' ARG . 53.5 tt0 -159.81 -36.2 0.06 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.471 -0.768 . . . . 0.0 109.777 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.488 ' OH ' ' CD1' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -45.71 -55.42 6.49 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.449 -0.782 . . . . 0.0 109.542 -179.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -129.06 30.61 5.02 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-O 121.682 0.754 . . . . 0.0 109.117 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.553 ' CD2' ' HA ' ' A' ' 16' ' ' ASP . 30.1 m-85 -128.86 -12.95 4.71 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.655 -0.653 . . . . 0.0 109.992 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.518 ' HB2' ' HA ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -128.29 52.04 1.93 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.1 -1.0 . . . . 0.0 109.381 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.401 ' O ' ' OG ' ' A' ' 22' ' ' SER . 11.4 t 176.36 41.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.386 -0.821 . . . . 0.0 109.237 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.2 t -139.1 -57.72 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.888 . . . . 0.0 109.409 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 2.4 mp -119.06 43.37 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.203 -0.936 . . . . 0.0 109.537 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.452 ' O ' ' OXT' ' A' ' 26' ' ' ALA . 9.1 ttpt -143.4 47.24 1.49 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.157 -0.965 . . . . 0.0 109.456 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.452 ' OXT' ' O ' ' A' ' 25' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.638 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -73.27 -59.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.98 1.516 . . . . 0.0 110.52 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 99.03 -159.45 20.1 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.489 ' O ' ' HD2' ' A' ' 6' ' ' LYS . 5.5 t -87.79 52.76 2.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.549 -0.971 . . . . 0.0 109.053 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.518 HG22 ' HB2' ' A' ' 7' ' ' GLU . 11.7 mt -71.48 -31.08 41.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.468 -0.77 . . . . 0.0 110.208 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.489 ' HD2' ' O ' ' A' ' 4' ' ' THR . 3.9 mttt 55.89 25.39 8.54 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 122.052 0.929 . . . . 0.0 108.503 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.894 ' O ' HD12 ' A' ' 9' ' ' ILE . 1.1 tt0 -140.29 64.61 1.44 Allowed 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.522 ' O ' ' C ' ' A' ' 9' ' ' ILE . 0.7 OUTLIER -73.42 57.17 0.52 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.631 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.894 HD12 ' O ' ' A' ' 7' ' ' GLU . 2.9 mp -25.07 -94.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 CA-C-O 121.334 0.588 . . . . 0.0 111.04 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.795 ' N ' HG22 ' A' ' 9' ' ' ILE . 2.5 mp 54.99 168.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 109.206 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.554 ' N ' HG22 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -80.84 54.23 2.11 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.333 -0.854 . . . . 0.0 109.211 -179.62 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.529 ' O ' ' CZ ' ' A' ' 15' ' ' TYR . . . 76.6 67.94 1.6 Allowed Glycine 0 N--CA 1.482 1.716 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 13' ' ' VAL . 10.8 p -67.47 40.15 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 O-C-N 121.956 -0.732 . . . . 0.0 111.439 -179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.412 ' H ' ' C ' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -89.61 37.47 0.87 Allowed 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.945 -1.097 . . . . 0.0 108.722 178.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.529 ' CZ ' ' O ' ' A' ' 12' ' ' GLY . 0.3 OUTLIER -162.16 31.04 0.12 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.595 ' HA ' ' CD1' ' A' ' 20' ' ' TYR . 2.7 t70 -161.66 31.62 0.13 Allowed 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.821 0.819 . . . . 0.0 108.893 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -134.18 -36.8 0.89 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.762 0.792 . . . . 0.0 109.215 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.423 ' CE1' ' HA ' ' A' ' 15' ' ' TYR . 53.5 p90 -97.71 -10.27 25.24 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.749 -0.594 . . . . 0.0 109.79 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.535 ' O ' ' CD1' ' A' ' 20' ' ' TYR . 34.7 ttp180 -120.73 37.22 4.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.275 -0.891 . . . . 0.0 109.281 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.595 ' CD1' ' HA ' ' A' ' 16' ' ' ASP . 54.8 m-85 -150.88 -40.13 0.13 Allowed 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.73 0.776 . . . . 0.0 108.939 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.475 ' O ' ' CB ' ' A' ' 22' ' ' SER . 0.3 OUTLIER -94.98 30.81 2.01 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 25' ' ' LYS . 2.3 p 163.15 59.89 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.725 HG13 ' CD1' ' A' ' 24' ' ' ILE . 1.6 p -41.73 -28.6 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.422 -0.799 . . . . 0.0 110.12 -179.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.725 ' CD1' HG13 ' A' ' 23' ' ' VAL . 2.6 mp -105.9 29.39 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.036 -1.04 . . . . 0.0 109.56 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 22' ' ' SER . 0.1 OUTLIER 66.16 -61.4 0.29 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.63 -0.669 . . . . 0.0 109.846 179.451 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 24' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.932 -1.033 . . . . 0.0 109.564 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.549 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 120.713 0.292 . . . . 0.0 110.383 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 1' ' ' MET . 48.8 Cg_endo -77.68 -177.29 3.74 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.915 1.482 . . . . 0.0 110.425 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 83.69 -171.92 49.72 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 4' ' ' THR . 11.2 t -104.94 42.51 1.2 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.349 -1.089 . . . . 0.0 109.756 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.2 mp -99.26 -27.39 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -0.883 . . . . 0.0 109.165 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 6' ' ' LYS . 8.9 mmmt 44.0 62.3 2.01 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.704 -0.623 . . . . 0.0 109.644 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -92.93 30.57 1.57 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.233 -0.917 . . . . 0.0 108.884 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -136.53 39.97 2.62 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.533 HG22 ' N ' ' A' ' 10' ' ' ILE . 17.0 mm -64.81 -102.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.543 -0.723 . . . . 0.0 110.218 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.722 ' N ' HD12 ' A' ' 10' ' ' ILE . 2.9 mp 56.54 168.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.089 -1.007 . . . . 0.0 109.426 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.62 ' N ' HG22 ' A' ' 10' ' ' ILE . 6.4 m-85 -78.0 51.43 0.97 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.303 -0.873 . . . . 0.0 109.458 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.17 -90.25 0.02 OUTLIER Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.737 HG22 ' CD1' ' A' ' 18' ' ' TYR . 0.7 OUTLIER -125.39 14.87 4.31 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.602 -0.94 . . . . 0.0 109.981 -179.466 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.78 87.83 6.33 Favored 'General case' 0 C--N 1.288 -2.082 0 O-C-N 121.469 -0.769 . . . . 0.0 110.068 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.455 ' O ' ' C ' ' A' ' 16' ' ' ASP . 0.5 OUTLIER -141.52 34.78 1.64 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.263 -0.898 . . . . 0.0 109.079 179.356 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.502 ' O ' ' HB2' ' A' ' 17' ' ' GLU . 32.8 t0 38.37 52.46 1.7 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 16' ' ' ASP . 33.1 tt0 166.93 -22.01 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.305 -0.872 . . . . 0.0 110.077 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.737 ' CD1' HG22 ' A' ' 13' ' ' VAL . 1.3 t80 -99.67 -3.15 33.69 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.166 -0.959 . . . . 0.0 109.299 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 13.6 ttm180 -91.09 30.48 1.22 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.228 -0.92 . . . . 0.0 108.692 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 53.61 48.64 21.19 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.785 -0.572 . . . . 0.0 109.892 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.464 ' O ' ' HB3' ' A' ' 22' ' ' SER . 0.0 OUTLIER -84.44 45.03 1.08 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.227 -0.921 . . . . 0.0 109.262 179.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 21' ' ' ARG . 6.7 t 72.16 46.61 0.32 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.137 -0.977 . . . . 0.0 109.43 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.614 HG13 ' N ' ' A' ' 24' ' ' ILE . 10.5 p -65.2 -49.94 76.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 O-C-N 121.025 -1.047 . . . . 0.0 109.471 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.78 HG22 ' O ' ' A' ' 24' ' ' ILE . 3.6 mt -140.53 27.46 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.132 -0.98 . . . . 0.0 108.876 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.518 ' C ' ' O ' ' A' ' 24' ' ' ILE . 15.8 mtmm 26.38 -92.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.326 0.584 . . . . 0.0 110.977 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 24' ' ' ILE . . . . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.52 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mtt . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 3' ' ' GLY . 50.1 Cg_endo -76.04 51.02 2.99 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.932 1.491 . . . . 0.0 110.164 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.492 ' O ' ' C ' ' A' ' 4' ' ' THR . . . 47.94 -174.95 0.02 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 4' ' ' THR . 7.7 t 34.63 68.32 0.2 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.831 -0.805 . . . . 0.0 110.145 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.4 mp -47.49 -21.59 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.268 -0.895 . . . . 0.0 109.845 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.61 55.4 1.92 Allowed 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.555 ' HG2' ' CD1' ' A' ' 9' ' ' ILE . 56.0 tt0 -74.47 50.47 0.42 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.495 -0.753 . . . . 0.0 109.316 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.487 ' O ' ' O ' ' A' ' 9' ' ' ILE . 0.4 OUTLIER -87.16 50.36 2.0 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.589 -0.694 . . . . 0.0 109.854 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.701 ' H ' HD12 ' A' ' 9' ' ' ILE . 2.9 mp -43.67 168.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.32 -0.863 . . . . 0.0 108.939 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.61 ' N ' HG22 ' A' ' 9' ' ' ILE . 1.8 mp -55.92 131.64 19.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.688 ' CG ' ' O ' ' A' ' 11' ' ' PHE . 5.2 t80 60.25 26.22 15.68 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.797 1.284 . . . . 0.0 108.024 -179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.46 -87.72 0.06 OUTLIER Glycine 0 N--CA 1.485 1.94 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.726 HG13 ' O ' ' A' ' 13' ' ' VAL . 0.4 OUTLIER -108.27 20.77 5.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 O-C-N 121.643 -0.916 . . . . 0.0 109.321 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.539 ' OG ' ' CB ' ' A' ' 18' ' ' TYR . 0.4 OUTLIER -64.88 -96.31 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.536 ' CB ' ' O ' ' A' ' 14' ' ' SER . 0.7 OUTLIER 77.62 75.8 0.07 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.235 -0.916 . . . . 0.0 111.356 178.25 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.479 ' C ' ' O ' ' A' ' 15' ' ' TYR . 19.4 t70 35.27 32.09 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 122.039 0.923 . . . . 0.0 109.765 179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -131.68 -29.35 1.73 Allowed 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.577 ' CE2' ' HB3' ' A' ' 21' ' ' ARG . 23.6 t80 -81.58 38.43 0.5 Allowed 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.484 -0.76 . . . . 0.0 110.095 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.525 ' O ' ' HG2' ' A' ' 19' ' ' ARG . 1.3 ttt85 46.58 34.26 2.36 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.916 -1.115 . . . . 0.0 109.003 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.619 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 0.0 OUTLIER 38.86 50.89 1.76 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.63 -0.669 . . . . 0.0 109.91 179.533 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.577 ' HB3' ' CE2' ' A' ' 18' ' ' TYR . 4.3 tpt85 -93.64 51.27 1.55 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.021 -1.049 . . . . 0.0 109.272 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.0 m -135.65 23.92 3.4 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.618 ' O ' HG12 ' A' ' 23' ' ' VAL . 75.6 t -92.64 53.77 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.747 HG23 ' O ' ' A' ' 24' ' ' ILE . 3.7 tp 42.39 32.8 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 121.485 0.66 . . . . 0.0 109.51 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER 38.31 46.1 0.87 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.818 -0.551 . . . . 0.0 110.021 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.28 179.843 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.543 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 120.585 0.231 . . . . 0.0 110.459 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 1' ' ' MET . 46.7 Cg_endo -74.09 114.76 4.11 Favored 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.886 1.466 . . . . 0.0 110.423 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.495 ' C ' HG22 ' A' ' 4' ' ' THR . . . 165.57 -163.55 36.71 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.495 HG22 ' C ' ' A' ' 3' ' ' GLY . 7.5 t 37.03 61.06 0.93 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.691 -0.888 . . . . 0.0 110.381 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.538 HG22 ' O ' ' A' ' 5' ' ' ILE . 5.7 mt -142.33 81.75 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.325 -0.86 . . . . 0.0 109.344 179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.32 53.21 1.01 Allowed 'General case' 0 C--N 1.296 -1.756 0 O-C-N 121.591 -0.693 . . . . 0.0 109.481 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -129.9 37.83 3.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.173 -0.954 . . . . 0.0 109.328 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.468 ' OD1' HG12 ' A' ' 10' ' ' ILE . 32.0 t30 -153.46 81.14 1.18 Allowed 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.521 ' O ' ' O ' ' A' ' 10' ' ' ILE . 1.2 mp -53.55 -17.75 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.259 -0.901 . . . . 0.0 110.728 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.601 ' O ' ' N ' ' A' ' 12' ' ' GLY . 9.6 mm -42.06 166.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.118 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.454 ' N ' HG22 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -65.66 54.6 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.305 -0.872 . . . . 0.0 109.326 -179.7 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 10' ' ' ILE . . . -83.42 -3.92 89.65 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.748 HG22 ' O ' ' A' ' 13' ' ' VAL . 15.0 p -99.7 32.45 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.251 -1.147 . . . . 0.0 110.05 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.579 ' O ' ' CD1' ' A' ' 15' ' ' TYR . 0.9 OUTLIER -123.13 23.4 9.22 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.482 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.579 ' CD1' ' O ' ' A' ' 14' ' ' SER . 4.5 m-85 -157.18 24.62 0.31 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.458 ' OD1' ' HA ' ' A' ' 23' ' ' VAL . 3.7 t70 -148.29 25.48 0.99 Allowed 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.696 ' OE1' HG22 ' A' ' 13' ' ' VAL . 33.8 mt-10 -141.41 5.54 1.85 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.569 ' O ' ' CD2' ' A' ' 18' ' ' TYR . 69.4 t80 -71.95 0.46 9.25 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 20' ' ' TYR . 12.7 ttm180 60.91 24.93 14.93 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.471 ' HB2' ' O ' ' A' ' 19' ' ' ARG . 0.3 OUTLIER 170.54 21.18 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.291 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.532 ' O ' ' CB ' ' A' ' 22' ' ' SER . 5.0 ttp180 -136.86 73.25 1.44 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.603 -1.31 . . . . 0.0 109.281 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 21' ' ' ARG . 0.8 OUTLIER 79.23 39.94 0.1 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.566 -0.709 . . . . 0.0 109.15 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.458 ' HA ' ' OD1' ' A' ' 16' ' ' ASP . 2.4 t -100.28 -52.43 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.786 HG22 ' O ' ' A' ' 24' ' ' ILE . 32.2 mm -103.87 32.87 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.346 -0.846 . . . . 0.0 108.981 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.521 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 1.5 tptt -179.3 102.05 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.521 ' HB2' ' O ' ' A' ' 25' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.492 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 120.759 0.314 . . . . 0.0 110.171 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.52 86.64 1.16 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 124.039 1.547 . . . . 0.0 110.366 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 158.97 177.68 32.27 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.752 HG23 ' O ' ' A' ' 4' ' ' THR . 13.5 t -102.95 52.86 0.78 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.276 -1.132 . . . . 0.0 109.521 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.49 ' O ' ' HB3' ' A' ' 6' ' ' LYS . 3.0 mp -79.15 -89.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.351 -0.843 . . . . 0.0 109.748 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 5' ' ' ILE . 47.5 tptt 74.11 45.22 0.22 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.339 -0.851 . . . . 0.0 109.257 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.484 ' O ' ' HB3' ' A' ' 8' ' ' ASN . 64.9 tt0 178.19 68.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.437 -0.789 . . . . 0.0 109.104 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.494 ' HB3' ' HA2' ' A' ' 12' ' ' GLY . 1.9 t-20 62.7 95.7 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.764 HG22 ' N ' ' A' ' 10' ' ' ILE . 9.4 mm -24.4 -99.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.264 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.764 ' N ' HG22 ' A' ' 9' ' ' ILE . 1.9 mp -34.77 92.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.791 -0.568 . . . . 0.0 110.386 -178.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 9' ' ' ILE . 1.1 m-85 18.14 45.45 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 10' ' ' ILE . . . 61.61 9.59 19.4 Favored Glycine 0 N--CA 1.497 2.745 0 C-N-CA 119.772 -1.204 . . . . 0.0 110.729 178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.558 HG13 ' O ' ' A' ' 13' ' ' VAL . 3.0 p 35.58 31.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.565 -0.962 . . . . 0.0 110.955 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.505 ' N ' ' O ' ' A' ' 12' ' ' GLY . 5.0 t -95.33 46.97 1.12 Allowed 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.304 -0.873 . . . . 0.0 109.25 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.462 ' O ' ' C ' ' A' ' 16' ' ' ASP . 54.7 m-85 -125.65 52.15 1.67 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.157 -0.965 . . . . 0.0 109.907 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.462 ' C ' ' O ' ' A' ' 15' ' ' TYR . 32.1 t0 38.3 52.67 1.69 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.584 -0.697 . . . . 0.0 109.88 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 21' ' ' ARG . 0.7 OUTLIER 48.23 59.5 4.24 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.472 -0.767 . . . . 0.0 109.198 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.418 ' O ' ' C ' ' A' ' 19' ' ' ARG . 2.4 t80 62.18 33.24 16.95 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.538 ' O ' ' CB ' ' A' ' 20' ' ' TYR . 4.8 ttt180 41.01 49.92 3.08 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.538 ' CB ' ' O ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER 162.87 -11.9 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.506 -0.877 . . . . 0.0 111.368 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.54 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 16.5 ttt180 60.44 44.12 12.41 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.738 -1.226 . . . . 0.0 108.862 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 25' ' ' LYS . 0.3 OUTLIER -126.76 48.25 2.2 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.467 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.2 p -47.1 -24.0 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.407 -0.808 . . . . 0.0 109.277 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.595 HG23 ' O ' ' A' ' 24' ' ' ILE . 0.1 OUTLIER -89.0 16.45 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.231 -0.918 . . . . 0.0 109.117 179.697 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.545 ' N ' ' O ' ' A' ' 22' ' ' SER . 0.0 OUTLIER 52.85 -113.05 0.74 Allowed 'General case' 0 C--N 1.294 -1.816 0 O-C-N 121.424 -0.798 . . . . 0.0 109.482 179.191 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 O-C-N 120.638 -1.289 . . . . 0.0 109.395 -179.977 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.432 ' HB3' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 120.754 0.311 . . . . 0.0 110.186 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 1' ' ' MET . 47.0 Cg_endo -73.21 170.84 18.9 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.045 1.55 . . . . 0.0 110.494 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 172.26 -167.69 40.67 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.721 HG23 ' O ' ' A' ' 4' ' ' THR . 8.6 t -83.36 47.05 1.2 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.138 -1.213 . . . . 0.0 109.447 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.849 HG22 ' O ' ' A' ' 5' ' ' ILE . 2.2 mt 25.92 67.13 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 CA-C-O 121.672 0.749 . . . . 0.0 110.624 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.583 ' HB2' ' O ' ' A' ' 5' ' ' ILE . 0.0 OUTLIER 165.05 52.3 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -163.43 58.88 0.18 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.801 -1.187 . . . . 0.0 110.262 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.413 ' C ' HD13 ' A' ' 9' ' ' ILE . 1.4 t-20 -108.49 41.22 1.61 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.107 -0.996 . . . . 0.0 108.737 179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.705 HD13 ' N ' ' A' ' 9' ' ' ILE . 1.5 mm -86.69 159.36 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 CA-C-O 121.577 0.703 . . . . 0.0 110.385 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.749 ' O ' HG22 ' A' ' 10' ' ' ILE . 4.4 mp -91.18 16.35 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-O 122.224 1.011 . . . . 0.0 108.766 178.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -135.68 22.02 3.35 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -101.25 49.51 1.05 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.703 HG22 ' O ' ' A' ' 13' ' ' VAL . 11.5 p -80.35 45.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 O-C-N 121.692 -0.887 . . . . 0.0 110.092 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.512 ' HB3' ' O ' ' A' ' 13' ' ' VAL . 2.2 t 65.59 73.84 0.39 Allowed 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.547 -0.721 . . . . 0.0 109.751 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.422 ' O ' ' C ' ' A' ' 16' ' ' ASP . 0.1 OUTLIER -133.97 51.83 2.1 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 16' ' ' ASP . 8.6 t0 43.49 60.8 2.47 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.441 -0.787 . . . . 0.0 109.485 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.465 ' C ' ' CG ' ' A' ' 18' ' ' TYR . 7.1 mt-10 46.89 63.68 1.84 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.339 -0.851 . . . . 0.0 109.416 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.479 ' O ' ' C ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER 44.56 51.88 7.82 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.413 -0.804 . . . . 0.0 109.016 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.524 ' O ' ' HG2' ' A' ' 19' ' ' ARG . 8.1 ttt180 39.43 41.65 0.74 Allowed 'General case' 0 N--CA 1.489 1.476 0 CA-C-O 121.809 0.814 . . . . 0.0 108.822 -179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.486 ' CD2' ' O ' ' A' ' 20' ' ' TYR . 65.1 t80 57.51 56.52 4.93 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.26 -0.9 . . . . 0.0 108.882 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 18' ' ' TYR . 4.8 ttt85 -167.88 90.55 0.31 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.396 -0.815 . . . . 0.0 109.559 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.58 ' O ' ' N ' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -87.79 58.39 4.84 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 179.003 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 22' ' ' SER . 13.1 p -37.73 -27.67 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.862 -0.524 . . . . 0.0 110.471 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.712 HG23 ' O ' ' A' ' 24' ' ' ILE . 0.7 OUTLIER -87.9 19.25 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 120.998 -1.064 . . . . 0.0 110.071 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.58 ' N ' ' O ' ' A' ' 22' ' ' SER . 1.4 tttt 42.82 -146.52 0.06 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.601 -0.687 . . . . 0.0 109.321 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' A' ' 25' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.446 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -79.56 45.01 1.83 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.957 1.504 . . . . 0.0 111.129 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 158.08 155.07 7.4 Favored Glycine 0 N--CA 1.491 2.352 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.237 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.842 HG23 ' O ' ' A' ' 4' ' ' THR . 8.1 t -125.93 65.11 1.2 Allowed 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.692 -0.887 . . . . 0.0 109.677 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.653 HG22 ' O ' ' A' ' 5' ' ' ILE . 6.6 mt -130.2 77.08 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 120.872 -1.143 . . . . 0.0 109.211 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.423 ' HE3' ' HB3' ' A' ' 6' ' ' LYS . 13.3 mmmt -133.96 57.46 1.81 Allowed 'General case' 0 C--N 1.292 -1.925 0 O-C-N 121.755 -0.591 . . . . 0.0 109.722 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 9' ' ' ILE . 8.7 tt0 -149.07 22.51 0.96 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.142 -0.974 . . . . 0.0 109.719 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.541 ' C ' ' O ' ' A' ' 7' ' ' GLU . 0.4 OUTLIER 8.34 59.83 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.659 0.784 . . . . 0.0 111.966 179.094 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 10' ' ' ILE . 14.5 mm -50.04 -102.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.731 -0.605 . . . . 0.0 110.143 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.661 ' N ' HD12 ' A' ' 10' ' ' ILE . 3.0 mp 53.72 169.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.116 -0.99 . . . . 0.0 108.822 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.602 ' N ' HG22 ' A' ' 10' ' ' ILE . 0.3 OUTLIER -86.93 49.04 1.74 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.802 -1.186 . . . . 0.0 109.374 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.489 ' HA2' ' HB3' ' A' ' 16' ' ' ASP . . . -152.88 12.75 0.63 Allowed Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.103 -1.522 . . . . 0.0 110.884 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 13' ' ' VAL . 10.9 p -94.21 14.08 2.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 120.979 -1.307 . . . . 0.0 110.125 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.521 ' C ' ' CG ' ' A' ' 15' ' ' TYR . 2.3 t 175.96 24.86 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.797 -0.564 . . . . 0.0 110.764 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.592 ' CD1' ' N ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -172.72 29.89 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.853 -1.154 . . . . 0.0 109.389 179.811 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.489 ' HB3' ' HA2' ' A' ' 12' ' ' GLY . 29.7 t0 -163.52 24.09 0.08 Allowed 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.764 0.792 . . . . 0.0 109.077 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -138.06 6.76 2.64 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -86.85 14.69 6.81 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.488 ' O ' ' HG2' ' A' ' 19' ' ' ARG . 20.0 ttt180 50.15 33.51 7.21 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.561 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 12.7 m-85 40.89 57.47 2.71 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.616 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.495 ' O ' ' CB ' ' A' ' 22' ' ' SER . 8.6 ttp85 -92.96 41.85 1.09 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.52 -0.737 . . . . 0.0 109.507 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.495 ' CB ' ' O ' ' A' ' 21' ' ' ARG . 0.4 OUTLIER 165.28 39.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.327 -0.858 . . . . 0.0 109.714 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.8 t -136.04 -58.81 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.326 -0.859 . . . . 0.0 108.993 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.755 HG23 ' O ' ' A' ' 24' ' ' ILE . 2.2 tp -88.03 31.71 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.351 -0.843 . . . . 0.0 109.735 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -156.59 151.84 26.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 0.0 109.447 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.153 -0.967 . . . . 0.0 109.498 -179.972 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 tpp . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.771 0.32 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.19 58.34 4.27 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.978 1.515 . . . . 0.0 110.371 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.534 ' O ' HD12 ' A' ' 5' ' ' ILE . . . -142.79 -178.32 18.59 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.513 HG22 ' C ' ' A' ' 3' ' ' GLY . 9.5 t 37.36 48.4 0.83 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.735 -0.862 . . . . 0.0 110.191 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.545 HG22 ' O ' ' A' ' 5' ' ' ILE . 7.8 mt -142.76 81.07 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.414 -0.804 . . . . 0.0 109.055 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.431 ' C ' ' HG3' ' A' ' 7' ' ' GLU . 6.2 tptp -148.93 79.25 1.41 Allowed 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.431 ' HG3' ' C ' ' A' ' 6' ' ' LYS . 22.5 mt-10 66.73 93.17 0.07 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.379 -0.826 . . . . 0.0 109.084 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.453 ' O ' ' CG ' ' A' ' 8' ' ' ASN . 1.5 p30 -74.14 47.38 0.28 Allowed 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.493 -0.754 . . . . 0.0 110.244 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.803 HG22 ' N ' ' A' ' 10' ' ' ILE . 2.1 mp -44.39 -90.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.112 -0.993 . . . . 0.0 110.094 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.803 ' N ' HG22 ' A' ' 9' ' ' ILE . 2.7 mp 61.12 126.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -178.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.66 ' CG ' ' O ' ' A' ' 11' ' ' PHE . 4.2 t80 62.74 18.93 11.06 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 122.394 1.092 . . . . 0.0 108.764 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 14' ' ' SER . . . -74.83 -69.55 1.38 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.522 ' O ' ' N ' ' A' ' 15' ' ' TYR . 5.7 p 33.57 34.12 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 121.412 0.625 . . . . 0.0 111.266 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.502 ' N ' ' O ' ' A' ' 12' ' ' GLY . 2.6 t 61.38 -76.46 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.364 -0.835 . . . . 0.0 109.795 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.544 ' CG ' ' O ' ' A' ' 15' ' ' TYR . 27.5 t80 56.02 25.83 9.28 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.237 -0.914 . . . . 0.0 108.777 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -168.5 27.78 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.645 0.736 . . . . 0.0 109.285 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -139.43 3.3 2.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.553 -0.717 . . . . 0.0 110.094 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -145.19 -37.99 0.27 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.937 -1.102 . . . . 0.0 109.818 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.3 ttm180 -106.53 36.14 2.72 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.655 0.74 . . . . 0.0 109.04 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -119.43 -4.39 10.39 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -137.65 58.43 1.7 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.273 -0.892 . . . . 0.0 109.396 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.529 ' HA ' ' HB2' ' A' ' 25' ' ' LYS . 1.9 p -152.95 31.72 0.49 Allowed 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.296 -0.878 . . . . 0.0 108.657 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.467 HG13 ' H ' ' A' ' 24' ' ' ILE . 2.0 p -56.05 -49.3 76.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.78 HG22 ' O ' ' A' ' 24' ' ' ILE . 36.0 mm -110.08 29.11 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.199 -0.938 . . . . 0.0 109.232 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.529 ' HB2' ' HA ' ' A' ' 22' ' ' SER . 11.8 tttp -84.17 122.13 28.42 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.969 -0.693 . . . . 0.0 109.373 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.601 -179.95 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ttp . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 120.793 0.33 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 3' ' ' GLY . 45.0 Cg_endo -73.31 130.95 15.76 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.054 1.555 . . . . 0.0 110.492 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 2' ' ' PRO . . . -55.49 -168.27 0.06 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.484 ' O ' HG13 ' A' ' 5' ' ' ILE . 8.8 t -90.79 37.84 0.93 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.24 -1.153 . . . . 0.0 109.318 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 5' ' ' ILE . 5.3 mt -142.42 79.03 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.589 -0.694 . . . . 0.0 109.43 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -158.22 45.85 0.33 Allowed 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.549 -0.72 . . . . 0.0 109.455 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -96.91 48.69 1.06 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.274 -0.891 . . . . 0.0 109.666 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -139.59 58.96 1.6 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.336 -0.852 . . . . 0.0 110.098 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.827 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.5 mp -99.93 -115.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.963 -1.086 . . . . 0.0 109.929 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.648 ' N ' HD12 ' A' ' 10' ' ' ILE . 2.7 mp 54.03 166.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 O-C-N 121.006 -1.059 . . . . 0.0 109.211 -179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.563 ' N ' HG22 ' A' ' 10' ' ' ILE . 6.2 m-85 -78.02 47.73 0.67 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.107 -0.996 . . . . 0.0 109.623 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -136.37 4.96 3.81 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.814 HG22 ' O ' ' A' ' 13' ' ' VAL . 7.1 p -88.19 36.7 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.324 -1.103 . . . . 0.0 109.41 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 14' ' ' SER . 4.1 t 54.66 37.38 28.07 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.154 -0.966 . . . . 0.0 108.682 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.451 ' O ' ' N ' ' A' ' 19' ' ' ARG . 0.4 OUTLIER 45.71 70.46 0.36 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.492 -0.755 . . . . 0.0 109.668 -179.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.495 ' H ' HG13 ' A' ' 13' ' ' VAL . 16.6 t70 39.95 59.81 1.85 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.499 -0.75 . . . . 0.0 110.263 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.481 ' O ' ' N ' ' A' ' 21' ' ' ARG . 2.4 mt-10 62.37 60.79 1.36 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.217 -0.927 . . . . 0.0 109.783 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.562 ' O ' ' CD2' ' A' ' 18' ' ' TYR . 84.5 t80 50.14 53.37 12.96 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.442 -0.787 . . . . 0.0 109.449 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.532 ' C ' ' CG ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER 39.78 63.73 0.98 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -179.383 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.578 ' N ' ' CD1' ' A' ' 20' ' ' TYR . 0.3 OUTLIER 69.96 65.54 0.23 Allowed 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.605 -0.684 . . . . 0.0 109.27 -179.548 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.536 ' O ' ' CB ' ' A' ' 22' ' ' SER . 0.3 OUTLIER -64.28 54.24 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.284 0.564 . . . . 0.0 109.873 179.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.548 ' N ' ' O ' ' A' ' 20' ' ' TYR . 0.7 OUTLIER 80.08 44.63 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.543 -0.723 . . . . 0.0 109.42 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.464 ' O ' ' C ' ' A' ' 24' ' ' ILE . 4.5 t -124.08 41.56 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.746 HG23 ' O ' ' A' ' 24' ' ' ILE . 8.2 tp 35.77 41.16 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 CA-C-O 121.293 0.568 . . . . 0.0 109.983 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.522 ' HG3' ' N ' ' A' ' 26' ' ' ALA . 1.8 pttm 40.75 -163.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.653 -0.655 . . . . 0.0 109.967 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.522 ' N ' ' HG3' ' A' ' 25' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.599 -179.941 . . . . . . . . 1 1 . 1 stop_ save_